
<!DOCTYPE html>
<html lang="en" >
    <head >

        <meta charset="UTF-8" />
        <meta http-equiv="X-UA-Compatible" content="IE=edge" />
        <meta name="HandheldFriendly" content="True" />
        <meta name="MobileOptimized" content="320" />
        <meta name="viewport" content="width=device-width, initial-scale=1.0" />

        
        

        
        
  <link rel="stylesheet" href="/static/assets/style-8258669d.css" />
<script type="module" crossorigin="" src="/static/assets/base_style-f4a99799.js"></script>

  <link rel="stylesheet" href="/static/assets/style-ef962842.css" />
<link rel="stylesheet" href="/static/assets/style-3ade8b5c.css" />
<script type="module" crossorigin="" src="/static/assets/article_style-d757a0dd.js"></script>

  
  
    <style>
  
  
  @media screen and (min-width: 64em) {
    div.pmc-wm {
      background: repeat-y;
      background-image: url("data:image/svg+xml,%3Csvg xmlns='http://www.w3.org/2000/svg' width='20' height='350' xmlns:xlink='http://www.w3.org/1999/xlink'%3E%3Cdefs%3E%3Cfilter x='-.02' y='0' width='1.05' height='1' id='c'%3E%3CfeFlood flood-color='%23FFF'/%3E%3CfeComposite in='SourceGraphic'/%3E%3C/filter%3E%3Ctext id='b' font-family='Helvetica' font-size='11pt' style='opacity:1;fill:%23005ea2;stroke:none;text-anchor:middle' x='175' y='14'%3E%3C/text%3E%3Cpath id='a' style='fill:%23005ea2' d='M0 8h350v3H0z'/%3E%3C/defs%3E%3Cuse xlink:href='%23a' transform='rotate(90 10 10)'/%3E%3Cuse xlink:href='%23b' transform='rotate(90 10 10)' filter='url(%23c)'/%3E%3C/svg%3E");
      padding-left: 3rem;
    }
  }
</style>

  



        
            <link rel="apple-touch-icon"
                  sizes="180x180"
                  href="/static/img/favicons/apple-touch-icon.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="48x48"
                  href="/static/img/favicons/favicon-48x48.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="32x32"
                  href="/static/img/favicons/favicon-32x32.png" />
            <link rel="icon"
                  type="image/png"
                  sizes="16x16"
                  href="/static/img/favicons/favicon-16x16.png" />
            <link rel="manifest" href="/static/img/favicons/site.webmanifest" />
            <link rel="mask-icon"
                  href="/static/img/favicons/safari-pinned-tab.svg"
                  color="#0071bc" />
            <meta name="msapplication-config"
                  content="/static/img/favicons/browserconfig.xml" />
            <meta name="theme-color" content="#ffffff" />
        

        <title>
            In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis - PMC
        </title>

        
        
  
  <!-- Logging params: Pinger defaults -->
<meta name="ncbi_app" content="cloudpmc-viewer" />
<meta name="ncbi_db" content="pmc" />
<meta name="ncbi_phid" content="DB2B0D10925FC2433C0D10001F82D7E0.m_1" />
<meta name="ncbi_pinger_stat_url" content="https://pmc.ncbi.nlm.nih.gov/stat" />
<!-- Logging params: Pinger custom -->
<meta name="ncbi_pdid" content="article" />
  
    <link rel="preconnect" href="https://www.google-analytics.com" />

    
        <link rel="preconnect" href="https://cdn.ncbi.nlm.nih.gov" />
    

    <!-- Include USWDS Init Script -->
    <script src="/static/assets/uswds-init.js"></script>


    <meta name="ncbi_domain" content="ijms">
<meta name="ncbi_type" content="fulltext">
<meta name="ncbi_pcid" content="journal">
<meta name="ncbi_feature" content="associated_data">
<link rel="canonical" href="https://pmc.ncbi.nlm.nih.gov/articles/PMC8430710/">
<meta name="robots" content="INDEX,NOFOLLOW,NOARCHIVE">
<meta name="citation_journal_title" content="International Journal of Molecular Sciences">
<meta name="citation_title" content="In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis">
<meta name="citation_author" content="Filipa Bezerra">
<meta name="citation_author_institution" content="Molecular Neurobiology Group, i3S-Instituto de Investigação e Inovação em Saúde, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal; carla.bezerra@ibmc.up.pt (F.B.); b12458@med.uminho.pt (P.G.); mjsaraiv@ibmc.up.pt (M.J.S.)">
<meta name="citation_author_institution" content="Departamento de Biologia Molecular, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal">
<meta name="citation_author" content="Christoph Niemietz">
<meta name="citation_author_institution" content="Medizinische Klinik B, Universitätsklinikum Münster, 48149 Münster, Germany; Christoph.Niemietz@taconic.com (C.N.); hepar@ume.de (H.H.J.S.); Andree.Zibert@ukmuenster.de (A.Z.)">
<meta name="citation_author" content="Hartmut H J Schmidt">
<meta name="citation_author_institution" content="Medizinische Klinik B, Universitätsklinikum Münster, 48149 Münster, Germany; Christoph.Niemietz@taconic.com (C.N.); hepar@ume.de (H.H.J.S.); Andree.Zibert@ukmuenster.de (A.Z.)">
<meta name="citation_author" content="Andree Zibert">
<meta name="citation_author_institution" content="Medizinische Klinik B, Universitätsklinikum Münster, 48149 Münster, Germany; Christoph.Niemietz@taconic.com (C.N.); hepar@ume.de (H.H.J.S.); Andree.Zibert@ukmuenster.de (A.Z.)">
<meta name="citation_author" content="Shuling Guo">
<meta name="citation_author_institution" content="Ionis Pharmaceuticals, Carlsbad, CA 92010, USA; sguo@ionisph.com (S.G.); bmonia@ionisph.com (B.P.M.)">
<meta name="citation_author" content="Brett P Monia">
<meta name="citation_author_institution" content="Ionis Pharmaceuticals, Carlsbad, CA 92010, USA; sguo@ionisph.com (S.G.); bmonia@ionisph.com (B.P.M.)">
<meta name="citation_author" content="Paula Gonçalves">
<meta name="citation_author_institution" content="Molecular Neurobiology Group, i3S-Instituto de Investigação e Inovação em Saúde, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal; carla.bezerra@ibmc.up.pt (F.B.); b12458@med.uminho.pt (P.G.); mjsaraiv@ibmc.up.pt (M.J.S.)">
<meta name="citation_author" content="Maria João Saraiva">
<meta name="citation_author_institution" content="Molecular Neurobiology Group, i3S-Instituto de Investigação e Inovação em Saúde, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal; carla.bezerra@ibmc.up.pt (F.B.); b12458@med.uminho.pt (P.G.); mjsaraiv@ibmc.up.pt (M.J.S.)">
<meta name="citation_author_institution" content="Departamento de Biologia Molecular, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal">
<meta name="citation_author" content="Maria Rosário Almeida">
<meta name="citation_author_institution" content="Molecular Neurobiology Group, i3S-Instituto de Investigação e Inovação em Saúde, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal; carla.bezerra@ibmc.up.pt (F.B.); b12458@med.uminho.pt (P.G.); mjsaraiv@ibmc.up.pt (M.J.S.)">
<meta name="citation_author_institution" content="Departamento de Biologia Molecular, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal">
<meta name="citation_publication_date" content="2021 Aug 31">
<meta name="citation_volume" content="22">
<meta name="citation_issue" content="17">
<meta name="citation_firstpage" content="9488">
<meta name="citation_doi" content="10.3390/ijms22179488">
<meta name="citation_pmid" content="34502397">
<meta name="citation_abstract_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8430710/">
<meta name="citation_fulltext_html_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8430710/">
<meta name="citation_pdf_url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8430710/pdf/ijms-22-09488.pdf">
<meta name="description" content="Transthyretin (TTR) proteolysis has been recognized as a complementary mechanism contributing to transthyretin-related amyloidosis (ATTR amyloidosis). Accordingly, amyloid deposits can be composed mainly of full-length TTR or contain a mixture of ...">
<meta name="og:title" content="In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis">
<meta name="og:type" content="article">
<meta name="og:site_name" content="PubMed Central (PMC)">
<meta name="og:description" content="Transthyretin (TTR) proteolysis has been recognized as a complementary mechanism contributing to transthyretin-related amyloidosis (ATTR amyloidosis). Accordingly, amyloid deposits can be composed mainly of full-length TTR or contain a mixture of ...">
<meta name="og:url" content="https://pmc.ncbi.nlm.nih.gov/articles/PMC8430710/">
<meta name="og:image" content="https://cdn.ncbi.nlm.nih.gov/pmc/cms/images/pmc-card-share.jpg?_=0">
<meta name="twitter:card" content="summary_large_image">
<meta name="twitter:site" content="@ncbi">
    
    

    </head>
    <body >
        
    <a class="usa-skipnav " href="#main-content">
      Skip to main content
    </a>


        
            

<section class="usa-banner " aria-label="Official website of the United States government" >
    <div class="usa-accordion">
        <header class="usa-banner__header">
            <div class="usa-banner__inner">
                <div class="grid-col-auto">
                    <img aria-hidden="true"
                         class="usa-banner__header-flag"
                         src="/static/img/us_flag.svg"
                         alt="" />
                </div>

                <div class="grid-col-fill tablet:grid-col-auto" aria-hidden="true">
                    <p class="usa-banner__header-text">
                        An official website of the United States government
                    </p>
                    <span class="usa-banner__header-action">Here's how you know</span>
                </div>

                



















    
        <button
            type="button"
        
    
    class="usa-accordion__button usa-banner__button
           

           
               
               
               
               
            

           
           
           
           "
    aria-expanded="false"
    aria-controls="gov-banner-default"
    
    data-testid="storybook-django-banner"
    
    >
    
        

        
                    <span class="usa-banner__button-text">Here's how you know</span>
                

        
    
        
            </button>
        


            </div>
        </header>

        <div class="usa-banner__content usa-accordion__content"
             id="gov-banner-default"
             hidden>
            <div class="grid-row grid-gap-lg">
                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-dot-gov.svg"
                         alt=""
                         aria-hidden="true" />
                    <div class="usa-media-block__body">
                        <p>
                            <strong>Official websites use .gov</strong>
                            <br />
                            A
                            <strong>.gov</strong> website belongs to an official
                            government organization in the United States.
                        </p>
                    </div>
                </div>

                <div class="usa-banner__guidance tablet:grid-col-6">
                    <img class="usa-banner__icon usa-media-block__img"
                         src="/static/img/icon-https.svg"
                         alt=""
                         aria-hidden="true" />

                    <div class="usa-media-block__body">
                        <p>
                            <strong>Secure .gov websites use HTTPS</strong>
                            <br />
                            A <strong>lock</strong> (
                            <span class="icon-lock">
                                <svg xmlns="http://www.w3.org/2000/svg"
                                     width="52"
                                     height="64"
                                     viewBox="0 0 52 64"
                                     class="usa-banner__lock-image"
                                     role="graphics-symbol"
                                     aria-labelledby="banner-lock-description"
                                     focusable="false">
                                    <title id="banner-lock-title">Lock</title>
                                    <desc id="banner-lock-description">
                                    Locked padlock icon
                                    </desc>
                                    <path fill="#000000"
                                          fill-rule="evenodd"
                                          d="M26 0c10.493 0 19 8.507 19 19v9h3a4 4 0 0 1 4 4v28a4 4 0 0 1-4 4H4a4 4 0 0 1-4-4V32a4 4 0 0 1 4-4h3v-9C7 8.507 15.507 0 26 0zm0 8c-5.979 0-10.843 4.77-10.996 10.712L15 19v9h22v-9c0-6.075-4.925-11-11-11z" />
                                </svg>
</span>) or <strong>https://</strong> means you've safely
                                connected to the .gov website. Share sensitive
                                information only on official, secure websites.
                            </p>
                        </div>
                    </div>
                </div>
            </div>
        </div>
    </section>

        

        
    
    
    

<div class="usa-overlay">
</div>



<header class="usa-header usa-header--extended usa-header--wide" data-header data-testid="header"    >
    <div class="ncbi-header">
        <div class="ncbi-header__container">
            <a class="ncbi-header__logo-container"
               href="https://www.ncbi.nlm.nih.gov/">
                <img alt="NCBI home page"
                     class="ncbi-header__logo-image"
                     src="/static/img/ncbi-logos/nih-nlm-ncbi--white.svg"
                     width="410"
                     height="100" />
            </a>

            <!-- Mobile menu hamburger button -->
            



















    
        <button
            type="button"
        
    
    class="usa-menu-btn ncbi-header__hamburger-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Show menu"
    data-testid="navMenuButton"
    
    >
    
        

        
                <svg aria-hidden="true"
                     class="ncbi-hamburger-icon"
                     fill="none"
                     focusable="false"
                     height="21"
                     viewBox="0 0 31 21"
                     width="31"
                     xmlns="http://www.w3.org/2000/svg">
                    <path clip-rule="evenodd"
                          d="M0.125 20.75H30.875V17.3333H0.125V20.75ZM0.125 12.2083H30.875V8.79167H0.125V12.2083ZM0.125 0.25V3.66667H30.875V0.25H0.125Z"
                          fill="#F1F1F1"
                          fill-rule="evenodd" />
                </svg>
            

        
    
        
            </button>
        



            
                <!-- Desktop buttons-->
                <div class="ncbi-header__desktop-buttons">
                    
                        <!-- Desktop search button -->
                        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button
           "
    aria-expanded="false"
    aria-controls="search-field-desktop-navigation"
    aria-label="Show search overlay"
    data-testid="toggleSearchPanelButton"
    data-toggle-search-panel-button
    >
    
        

        
                            



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#search" />
    </svg>


                            Search
                        

        
    
        
            </button>
        


                    

                    <!-- Desktop login dropdown -->
                    
                        <div class="ncbi-header__login-dropdown">
                            



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--unstyled ncbi-header__desktop-button ncbi-header__login-dropdown-button
           "
    aria-expanded="false"
    aria-controls="login-dropdown-menu"
    aria-label="Show login menu"
    data-testid="toggleLoginMenuDropdown"
    data-desktop-login-button
    >
    
        

        
                                



    <svg class="usa-icon " role="graphics-symbol" aria-hidden="true" >
        
        <use xlink:href="/static/img/sprite.svg#person" />
    </svg>



                                <span data-login-dropdown-text>Log in</span>

                                <!-- Dropdown icon pointing up -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-less ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-up-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_less" />
    </svg>



                                <!-- Dropdown icon pointing down -->
                                



    <svg class="usa-icon ncbi-header__login-dropdown-icon ncbi-header__login-dropdown-icon--expand-more ncbi-header__login-dropdown-icon--hidden" role="graphics-symbol" aria-hidden="true" data-login-dropdown-down-arrow>
        
        <use xlink:href="/static/img/sprite.svg#expand_more" />
    </svg>


                            

        
    
        
            </button>
        



                            <!-- Login dropdown menu -->
                            <ul class="usa-nav__submenu ncbi-header__login-dropdown-menu"
                                id="login-dropdown-menu"
                                data-desktop-login-menu-dropdown
                                hidden>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                                    </li>
                                
                                    <li class="usa-nav__submenu-item">
                                        <!-- Uses custom style overrides to render external and document links. -->
                                        









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                                    </li>
                                
                                <li class="usa-nav__submenu-item">
                                    



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           usa-button--outline ncbi-header__login-dropdown-logout-button
           "
    
    
    
    data-testid="desktopLogoutButton"
    data-desktop-logout-button
    >
    
        

        Log out

        
    
        
            </button>
        


                                </li>
                            </ul>
                        </div>
                    
                </div>
            
        </div>
    </div>

    <!-- Search panel -->
    
        <div class="ncbi-search-panel ncbi--show-only-at-desktop"
             data-header-search-panel
             hidden>
            <div class="ncbi-search-panel__container">
                <form action="https://www.ncbi.nlm.nih.gov/search/all/"
                      
                      autocomplete="off"
                      class="usa-search usa-search--big ncbi-search-panel__form"
                      data-testid="desktop-navigation-search-form"
                      method="GET"
                      role="search">
                    <label class="usa-sr-only" for="search-field-desktop-navigation">
                        Search…
                    </label>
                    <input class="usa-input"
                           id="search-field-desktop-navigation"
                           name="term"
                           
                               placeholder="Search NCBI"
                           
                           type="search"
                           value="" />
                    



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                        <span class="usa-search__submit-text">
                            Search NCBI
                        </span>
                    

        
    
        
            </button>
        


                </form>

                
            </div>
        </div>
    

    <nav aria-label="Primary navigation" class="usa-nav">
        <p class="usa-sr-only" id="primary-navigation-sr-only-title">
            Primary site navigation
        </p>

        <!-- Mobile menu close button -->
        



















    
        <button
            type="button"
        
    
    class="usa-nav__close ncbi-nav__close-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    aria-label="Close navigation menu"
    data-testid="navCloseButton"
    
    >
    
        

        
            <img src="/static/img/usa-icons/close.svg" alt="Close" />
        

        
    
        
            </button>
        



        
            <!-- Mobile search component -->
            <form class="usa-search usa-search--small ncbi--hide-at-desktop margin-top-6"
                  action="https://www.ncbi.nlm.nih.gov/search/all/"
                  
                  autocomplete="off"
                  data-testid="mobile-navigation-search-form"
                  method="GET"
                  role="search">
                <label class="usa-sr-only" for="search-field-mobile-navigation">
                    Search
                </label>

                <input class="usa-input"
                       id="search-field-mobile-navigation"
                       type="search"
                       
                           placeholder="Search NCBI"
                       
                       name="term" />

                



















    
        <button
            type="submit"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           
           "
    
    
    
    
    
    >
    
        

        
                    <!-- This SVG should be kept inline and not replaced with a link to the icon as otherwise it will render in the wrong color -->
                    <img src="data:image/svg+xml;base64,PHN2ZyB4bWxucz0iaHR0cDovL3d3dy53My5vcmcvMjAwMC9zdmciIGhlaWdodD0iMjQiIHZpZXdCb3g9IjAgMCAyNCAyNCIgd2lkdGg9IjI0Ij48cGF0aCBkPSJNMCAwaDI0djI0SDB6IiBmaWxsPSJub25lIi8+PHBhdGggZmlsbD0iI2ZmZiIgZD0iTTE1LjUgMTRoLS43OWwtLjI4LS4yN0E2LjQ3MSA2LjQ3MSAwIDAgMCAxNiA5LjUgNi41IDYuNSAwIDEgMCA5LjUgMTZjMS42MSAwIDMuMDktLjU5IDQuMjMtMS41N2wuMjcuMjh2Ljc5bDUgNC45OUwyMC40OSAxOWwtNC45OS01em0tNiAwQzcuMDEgMTQgNSAxMS45OSA1IDkuNVM3LjAxIDUgOS41IDUgMTQgNy4wMSAxNCA5LjUgMTEuOTkgMTQgOS41IDE0eiIvPjwvc3ZnPg=="
                         class="usa-search__submit-icon"
                         alt="Search" />
                

        
    
        
            </button>
        


            </form>

            
        

        <!-- Primary navigation menu items -->
        <!-- This usa-nav__inner wrapper is required to correctly style the navigation items on Desktop -->
        

        
            <div class="ncbi-nav__mobile-login-menu ncbi--hide-at-desktop"
                 data-mobile-login-menu
                 hidden>
                <p class="ncbi-nav__mobile-login-menu-status">
                    Logged in as:
                    <strong class="ncbi-nav__mobile-login-menu-email"
                            data-mobile-login-email-text></strong>
                </p>
                <ul class="usa-nav__primary usa-accordion">
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/" class="usa-link  "  >
        

        
            Dashboard
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/myncbi/collections/bibliography/" class="usa-link  "  >
        

        
            Publications
        

        
    </a>


                        </li>
                    
                        <li class="usa-nav__primary-item">
                            









    <a href="https://www.ncbi.nlm.nih.gov/account/settings/" class="usa-link  "  >
        

        
            Account settings
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        

        



















    
        <button
            type="button"
        
    
    class="usa-button
           

           
               
               
               
               
            

           
           
           ncbi-nav__mobile-login-button ncbi--hide-at-desktop
           "
    
    
    
    data-testid="mobileLoginButton"
    data-mobile-login-button
    >
    
        

        Log in

        
    
        
            </button>
        


    </nav>
</header>

    
    
        

<section class="pmc-header pmc-header--basic" aria-label="PMC Header with search box">
    <div class="pmc-nav-container">
        <div class="pmc-header__bar">
           <div class="pmc-header__logo">
               <a href="/" title="Home" aria-label="PMC Home"></a>
           </div>
            <button
                    type="button"
                    class="usa-button usa-button--unstyled pmc-header__search__button"
                    aria-label="Open search"
                    data-ga-category="search"
                    data-ga-action="PMC"
                    data-ga-label="pmc_search_panel_mobile"
            >
                <svg class="usa-icon width-4 height-4 pmc-icon__open" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#search"></use>
                </svg>
                <svg class="usa-icon width-4 height-4 pmc-icon__close" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
            </button>
        </div>
        <div class="pmc-header__search">
            


<form class="usa-search usa-search--extra usa-search--article-right-column  pmc-header__search__form" id="pmc-search-form" autocomplete="off" role="search">
<label class="usa-sr-only" for="pmc-search">Search PMC Full-Text Archive</label>
<span class="autoComplete_wrapper flex-1">
<input class="usa-input width-full maxw-none" required="required" placeholder="Search PMC Full-Text Archive" id="pmc-search"  type="search" name="term" data-autocomplete-url="https://pmc.ncbi.nlm.nih.gov/autocomp/search/autocomp/"/>
</span>
<button
class="usa-button"
type="submit"
formaction="https://pmc.ncbi.nlm.nih.gov/search/"
data-ga-category="search"
data-ga-action="PMC"
data-ga-label="PMC_search_button"
>
<span class="usa-search__submit-text">Search in PMC</span>
<img
src="/static/img/usa-icons-bg/search--white.svg"
class="usa-search__submit-icon"
alt="Search"
/>
</button>
</form>
            <div class="display-flex flex-column tablet:flex-row tablet:flex-justify flex-justify-center flex-align-center width-full desktop:maxw-44">
                <ul class="pmc-header__search__menu">
                    <li>
                        
                            <a class="usa-link" href="/journals/" data-ga-action="featured_link" data-ga-label="journal list">
                                Journal List
                            </a>
                        
                    </li>
                    <li>
                        
                            <a class="usa-link" href="/about/userguide/" data-ga-action="featured_link"
                            data-ga-label="user guide">
                                User Guide
                            </a>
                        
                    </li>
                </ul>
            </div>
        </div>
    </div>
</section>

    


        
        

       
  <div class="usa-section padding-top-0 desktop:padding-top-6 pmc-article-section" data-article-db="pmc" data-article-id="8430710">

    

   



<div class="grid-container pmc-actions-bar" aria-label="Actions bar" role="complementary">
    <div class="grid-row">
        <div class="grid-col-fill display-flex">
             <div class="display-flex">
                <ul class="usa-list usa-list--unstyled usa-list--horizontal">
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <button
                                type="button"
                                class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                                aria-label="Open resources"
                                data-extra-class="is-visible-resources"
                                data-ga-category="resources_accordion"
                                data-ga-action="click"
                                data-ga-label="mobile_icon"
                        >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#more_vert"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex mob">
                        <a
                                href="https://doi.org/10.3390/ijms22179488"
                                class="usa-link display-flex usa-tooltip"
                                role="button"
                                target="_blank"
                                rel="noreferrer noopener"
                                title="View on publisher site"
                                data-position="bottom"
                                aria-label="View on publisher site"
                                data-ga-category="actions"
                                data-ga-action="click"
                                data-ga-label="publisher_link_mobile"
                        >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#launch"></use>
                                </svg>
                        </a>
                    </li>
                    
                    
                        <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                             <a
                                     href="pdf/ijms-22-09488.pdf"
                                     class="usa-link display-flex usa-tooltip"
                                     role="button"
                                     title="Download PDF"
                                     data-position="bottom"
                                     aria-label="Download PDF"
                                     data-ga-category="actions"
                                     data-ga-action="click"
                                     data-ga-label="pdf_download_mobile"
                             >
                                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                                </svg>
                            </a>
                        </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button
                            class="usa-button usa-button--unstyled  usa-tooltip collections-dialog-trigger collections-button display-flex collections-button-empty"
                            title="Add to Collections"
                            data-position="bottom"
                            aria-label="Save article in MyNCBI collections."
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="collections_button_mobile"
                            data-collections-open-dialog-enabled="false"
                            data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8430710%2F%23open-collections-dialog"
                            data-in-collections="false"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="margin-right-2 mobile-lg:margin-right-4 display-flex">
                        <button role="button" class="usa-button usa-button--unstyled usa-tooltip citation-dialog-trigger display-flex"
                            aria-label="Open dialog with citation text in different styles"
                            title="Cite"
                            data-position="bottom"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="cite_mobile"
                            data-all-citations-url="/resources/citations/8430710/"
                            data-citation-style="nlm"
                            data-download-format-link="/resources/citations/8430710/export/"
                        >
                            <svg class="usa-icon width-4 height-4 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                            </svg>
                        </button>
                    </li>
                    
                    <li class="pmc-permalink display-flex" >
                         <button
                                 type="button"
                                 title="Permalink"
                                 data-position="bottom"
                                 class="usa-button usa-button--unstyled display-flex usa-tooltip"
                                 aria-label="Show article permalink"
                                 aria-expanded="false"
                                 aria-haspopup="true"
                                 data-ga-category="actions"
                                 data-ga-action="open"
                                 data-ga-label="permalink_mobile"
                         >
                            <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                                <use xlink:href="/static/img/sprite.svg#share"></use>
                            </svg>
                        </button>
                        

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8430710/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
                    </li>
                </ul>
            </div>
            <button
                    type="button"
                    class="usa-button pmc-sidenav__container__open usa-button--unstyled width-auto display-flex"
                    aria-label="Open article navigation"
                    data-extra-class="is-visible-in-page"
                    data-ga-category="actions"
                    data-ga-action="open"
                    data-ga-label="article_nav_mobile"
            >
                <svg class="usa-icon width-4 height-4" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#list"></use>
                </svg>
            </button>
        </div>
    </div>
</div>
    <div class="grid-container desktop:padding-left-6">
      <div id="article-container" class="grid-row grid-gap">
        <div class="grid-col-12 desktop:grid-col-8 order-2 pmc-layout__content">
            <div class="grid-container padding-left-0 padding-right-0">
                <div class="grid-row desktop:margin-left-neg-6">
                    <div class="grid-col-12">
                        <div class="pmc-layout__disclaimer" role="complementary" aria-label="Disclaimer note">
    As a library, NLM provides access to scientific literature. Inclusion in an NLM database does not imply endorsement of, or agreement with,
    the contents by NLM or the National Institutes of Health.<br/>
    Learn more:
    <a class="usa-link" data-ga-category="Link click" data-ga-action="Disclaimer" data-ga-label="New disclaimer box" href="/about/disclaimer/">PMC Disclaimer</a>
    |
    <a class="usa-link" data-ga-category="Link click" data-ga-action="PMC Copyright Notice" data-ga-label="New disclaimer box" href="/about/copyright/">
        PMC Copyright Notice
    </a>
</div>
                    </div>
                </div>
                <div class="grid-row pmc-wm desktop:margin-left-neg-6">
                    <!-- Main content -->
                    <main
                      id="main-content"
                      class="usa-layout-docs__main usa-layout-docs grid-col-12 pmc-layout pmc-prose padding-0"
                    >

                      
                        <section class="pmc-journal-banner text-center line-height-none" aria-label="Journal banner"><img src="https://cdn.ncbi.nlm.nih.gov/pmc/banners/logo-ijms.png" alt="International Journal of Molecular Sciences logo" usemap="#pmc-banner-imagemap" width="500" height="75"><map name="pmc-banner-imagemap"><area alt="Link to International Journal of Molecular Sciences" title="Link to International Journal of Molecular Sciences" shape="default" href="http://www.mdpi.com/journal/ijms/" target="_blank" rel="noopener noreferrer"></map></section><article lang="en"><section aria-label="Article citation and metadata"><section class="pmc-layout__citation font-secondary font-xs"><div>
<div class="display-inline-block"><button type="button" class="cursor-pointer text-no-underline bg-transparent border-0 padding-0 text-left margin-0 text-normal text-primary" aria-controls="journal_context_menu">Int J Mol Sci</button></div>. 2021 Aug 31;22(17):9488. doi: <a href="https://doi.org/10.3390/ijms22179488" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">10.3390/ijms22179488</a>
</div>
<nav id="journal_context_menu" hidden="hidden"><ul class="menu-list font-family-ui" role="menu">
<li role="presentation"><a href="https://pmc.ncbi.nlm.nih.gov/search/?term=%22Int%20J%20Mol%20Sci%22%5Bjour%5D" class="usa-link" role="menuitem">Search in PMC</a></li>
<li role="presentation"><a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Int%20J%20Mol%20Sci%22%5Bjour%5D" lang="en" class="usa-link" role="menuitem">Search in PubMed</a></li>
<li role="presentation"><a href="https://www.ncbi.nlm.nih.gov/nlmcatalog?term=%22Int%20J%20Mol%20Sci%22%5BTitle%20Abbreviation%5D" class="usa-link" role="menuitem">View in NLM Catalog</a></li>
<li role="presentation"><a href="?term=%22Int%20J%20Mol%20Sci%22%5Bjour%5D" class="usa-link" role="menuitem" data-add-to-search="true">Add to search</a></li>
</ul></nav></section><section class="front-matter"><div class="ameta p font-secondary font-xs">
<hgroup><h1>In Vitro and In Vivo Effects of SerpinA1 on the Modulation of Transthyretin Proteolysis</h1></hgroup><div class="cg p">
<a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bezerra%20F%22%5BAuthor%5D" class="usa-link" aria-describedby="id1"><span class="name western">Filipa Bezerra</span></a><div hidden="hidden" id="id1">
<h3><span class="name western">Filipa Bezerra</span></h3>
<div class="p">
<sup>1</sup>Molecular Neurobiology Group, i3S-Instituto de Investigação e Inovação em Saúde, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal; carla.bezerra@ibmc.up.pt (F.B.); b12458@med.uminho.pt (P.G.); mjsaraiv@ibmc.up.pt (M.J.S.)</div>
<div class="p">
<sup>2</sup>Departamento de Biologia Molecular, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Bezerra%20F%22%5BAuthor%5D" class="usa-link"><span class="name western">Filipa Bezerra</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Niemietz%20C%22%5BAuthor%5D" class="usa-link" aria-describedby="id2"><span class="name western">Christoph Niemietz</span></a><div hidden="hidden" id="id2">
<h3><span class="name western">Christoph Niemietz</span></h3>
<div class="p">
<sup>3</sup>Medizinische Klinik B, Universitätsklinikum Münster, 48149 Münster, Germany; Christoph.Niemietz@taconic.com (C.N.); hepar@ume.de (H.H.J.S.); Andree.Zibert@ukmuenster.de (A.Z.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Niemietz%20C%22%5BAuthor%5D" class="usa-link"><span class="name western">Christoph Niemietz</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schmidt%20HHJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id3"><span class="name western">Hartmut H J Schmidt</span></a><div hidden="hidden" id="id3">
<h3><span class="name western">Hartmut H J Schmidt</span></h3>
<div class="p">
<sup>3</sup>Medizinische Klinik B, Universitätsklinikum Münster, 48149 Münster, Germany; Christoph.Niemietz@taconic.com (C.N.); hepar@ume.de (H.H.J.S.); Andree.Zibert@ukmuenster.de (A.Z.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Schmidt%20HHJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Hartmut H J Schmidt</span></a>
</div>
</div>
<sup>3,</sup><sup>†</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zibert%20A%22%5BAuthor%5D" class="usa-link" aria-describedby="id4"><span class="name western">Andree Zibert</span></a><div hidden="hidden" id="id4">
<h3><span class="name western">Andree Zibert</span></h3>
<div class="p">
<sup>3</sup>Medizinische Klinik B, Universitätsklinikum Münster, 48149 Münster, Germany; Christoph.Niemietz@taconic.com (C.N.); hepar@ume.de (H.H.J.S.); Andree.Zibert@ukmuenster.de (A.Z.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Zibert%20A%22%5BAuthor%5D" class="usa-link"><span class="name western">Andree Zibert</span></a>
</div>
</div>
<sup>3</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guo%20S%22%5BAuthor%5D" class="usa-link" aria-describedby="id5"><span class="name western">Shuling Guo</span></a><div hidden="hidden" id="id5">
<h3><span class="name western">Shuling Guo</span></h3>
<div class="p">
<sup>4</sup>Ionis Pharmaceuticals, Carlsbad, CA 92010, USA; sguo@ionisph.com (S.G.); bmonia@ionisph.com (B.P.M.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Guo%20S%22%5BAuthor%5D" class="usa-link"><span class="name western">Shuling Guo</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Monia%20BP%22%5BAuthor%5D" class="usa-link" aria-describedby="id6"><span class="name western">Brett P Monia</span></a><div hidden="hidden" id="id6">
<h3><span class="name western">Brett P Monia</span></h3>
<div class="p">
<sup>4</sup>Ionis Pharmaceuticals, Carlsbad, CA 92010, USA; sguo@ionisph.com (S.G.); bmonia@ionisph.com (B.P.M.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Monia%20BP%22%5BAuthor%5D" class="usa-link"><span class="name western">Brett P Monia</span></a>
</div>
</div>
<sup>4</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gon%C3%A7alves%20P%22%5BAuthor%5D" class="usa-link" aria-describedby="id7"><span class="name western">Paula Gonçalves</span></a><div hidden="hidden" id="id7">
<h3><span class="name western">Paula Gonçalves</span></h3>
<div class="p">
<sup>1</sup>Molecular Neurobiology Group, i3S-Instituto de Investigação e Inovação em Saúde, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal; carla.bezerra@ibmc.up.pt (F.B.); b12458@med.uminho.pt (P.G.); mjsaraiv@ibmc.up.pt (M.J.S.)</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Gon%C3%A7alves%20P%22%5BAuthor%5D" class="usa-link"><span class="name western">Paula Gonçalves</span></a>
</div>
</div>
<sup>1</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Saraiva%20MJ%22%5BAuthor%5D" class="usa-link" aria-describedby="id8"><span class="name western">Maria João Saraiva</span></a><div hidden="hidden" id="id8">
<h3><span class="name western">Maria João Saraiva</span></h3>
<div class="p">
<sup>1</sup>Molecular Neurobiology Group, i3S-Instituto de Investigação e Inovação em Saúde, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal; carla.bezerra@ibmc.up.pt (F.B.); b12458@med.uminho.pt (P.G.); mjsaraiv@ibmc.up.pt (M.J.S.)</div>
<div class="p">
<sup>2</sup>Departamento de Biologia Molecular, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Saraiva%20MJ%22%5BAuthor%5D" class="usa-link"><span class="name western">Maria João Saraiva</span></a>
</div>
</div>
<sup>1,</sup><sup>2</sup>, <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Almeida%20MR%22%5BAuthor%5D" class="usa-link" aria-describedby="id9"><span class="name western">Maria Rosário Almeida</span></a><div hidden="hidden" id="id9">
<h3><span class="name western">Maria Rosário Almeida</span></h3>
<div class="p">
<sup>1</sup>Molecular Neurobiology Group, i3S-Instituto de Investigação e Inovação em Saúde, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal; carla.bezerra@ibmc.up.pt (F.B.); b12458@med.uminho.pt (P.G.); mjsaraiv@ibmc.up.pt (M.J.S.)</div>
<div class="p">
<sup>2</sup>Departamento de Biologia Molecular, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal</div>
<div class="p">Find articles by <a href="https://pubmed.ncbi.nlm.nih.gov/?term=%22Almeida%20MR%22%5BAuthor%5D" class="usa-link"><span class="name western">Maria Rosário Almeida</span></a>
</div>
</div>
<sup>1,</sup><sup>2,</sup><sup>*</sup>
</div>
<div class="cg p">Editor: <span class="name western">Masaru Tanaka</span>
</div>
<ul class="d-buttons inline-list">
<li><button class="d-button" aria-controls="aip_a" aria-expanded="false">Author information</button></li>
<li><button class="d-button" aria-controls="anp_a" aria-expanded="false">Article notes</button></li>
<li><button class="d-button" aria-controls="clp_a" aria-expanded="false">Copyright and License information</button></li>
</ul>
<div class="d-panels font-secondary-light">
<div id="aip_a" class="d-panel p" style="display: none">
<div class="p" id="af1-ijms-22-09488">
<sup>1</sup>Molecular Neurobiology Group, i3S-Instituto de Investigação e Inovação em Saúde, IBMC-Instituto de Biologia Molecular e Celular, Universidade do Porto, 4200-135 Porto, Portugal; carla.bezerra@ibmc.up.pt (F.B.); b12458@med.uminho.pt (P.G.); mjsaraiv@ibmc.up.pt (M.J.S.)</div>
<div id="af2-ijms-22-09488">
<sup>2</sup>Departamento de Biologia Molecular, ICBAS-Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, 4050-313 Porto, Portugal</div>
<div id="af3-ijms-22-09488">
<sup>3</sup>Medizinische Klinik B, Universitätsklinikum Münster, 48149 Münster, Germany; Christoph.Niemietz@taconic.com (C.N.); hepar@ume.de (H.H.J.S.); Andree.Zibert@ukmuenster.de (A.Z.)</div>
<div id="af4-ijms-22-09488">
<sup>4</sup>Ionis Pharmaceuticals, Carlsbad, CA 92010, USA; sguo@ionisph.com (S.G.); bmonia@ionisph.com (B.P.M.)</div>
<div class="author-notes p">
<div class="fn" id="c1-ijms-22-09488">
<sup>*</sup><p class="display-inline">Correspondence: <span>ralmeida@ibmc.up.pt</span></p>
</div>
<div class="fn" id="fn1-ijms-22-09488">
<sup>†</sup><p class="display-inline">Present address: Universitätsklinikum Essen, Germany.</p>
</div>
</div>
<h4 class="font-secondary">Roles</h4>
<div class="p">
<strong class="contrib"><span class="name western">Masaru Tanaka</span></strong>: <span class="role">Academic Editor</span>
</div>
</div>
<div id="anp_a" class="d-panel p" style="display: none"><div class="notes p"><section id="historyarticle-meta1" class="history"><p>Received 2021 Jul 20; Accepted 2021 Aug 28; Collection date 2021 Sep.</p></section></div></div>
<div id="clp_a" class="d-panel p" style="display: none">
<div>© 2021 by the authors.</div>
<p>Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (<a href="https://creativecommons.org/licenses/by/4.0/" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">https://creativecommons.org/licenses/by/4.0/</a>).</p>
<div class="p"><a href="/about/copyright/" class="usa-link">PMC Copyright notice</a></div>
</div>
</div>
<div>PMCID: PMC8430710  PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/34502397/" class="usa-link">34502397</a>
</div>
</div></section></section><section aria-label="Article content"><section class="body main-article-body"><section class="abstract" id="abstract1"><h2>Abstract</h2>
<p>Transthyretin (TTR) proteolysis has been recognized as a complementary mechanism contributing to transthyretin-related amyloidosis (ATTR amyloidosis). Accordingly, amyloid deposits can be composed mainly of full-length TTR or contain a mixture of both cleaved and full-length TTR, particularly in the heart. The fragmentation pattern at Lys48 suggests the involvement of a serine protease, such as plasmin. The most common TTR variant, TTR V30M, is susceptible to plasmin-mediated proteolysis, and the presence of TTR fragments facilitates TTR amyloidogenesis. Recent studies revealed that the serine protease inhibitor, SerpinA1, was differentially expressed in hepatocyte-like cells (HLCs) from ATTR patients. In this work, we evaluated the effects of SerpinA1 on in vitro and in vivo modulation of TTR V30M proteolysis, aggregation, and deposition. We found that plasmin-mediated TTR proteolysis and aggregation are partially inhibited by SerpinA1. Furthermore, in vivo downregulation of SerpinA1 increased TTR levels in mice plasma and deposition in the cardiac tissue of older animals. The presence of TTR fragments was observed in the heart of young and old mice but not in other tissues following SerpinA1 knockdown. Increased proteolytic activity, particularly plasmin activity, was detected in mice plasmas. Overall, our results indicate that SerpinA1 modulates TTR proteolysis and aggregation in vitro and in vivo.</p>
<section id="kwd-group1" class="kwd-group"><p><strong>Keywords:</strong> transthyretin, SerpinA1, ATTR amyloidosis, TTR proteolysis, plasmin</p></section></section><section id="sec1-ijms-22-09488"><h2 class="pmc_sec_title">1. Introduction</h2>
<p>Transthyretin-related amyloidoses (ATTR amyloidosis) are characterized by extracellular deposition of insoluble TTR amyloid fibrils in several tissues, being polyneuropathy and cardiomyopathy the major clinical manifestations, as reviewed in [<a href="#B1-ijms-22-09488" class="usa-link" aria-describedby="B1-ijms-22-09488">1</a>,<a href="#B2-ijms-22-09488" class="usa-link" aria-describedby="B2-ijms-22-09488">2</a>]. There are two types of ATTR amyloidoses: hereditary amyloidosis (ATTRm) and wild-type ATTR amyloidosis (ATTRwt) [<a href="#B3-ijms-22-09488" class="usa-link" aria-describedby="B3-ijms-22-09488">3</a>]. ATTRm occurs through single-residue substitutions in TTR, mainly producing less stable variants [<a href="#B4-ijms-22-09488" class="usa-link" aria-describedby="B4-ijms-22-09488">4</a>,<a href="#B5-ijms-22-09488" class="usa-link" aria-describedby="B5-ijms-22-09488">5</a>,<a href="#B6-ijms-22-09488" class="usa-link" aria-describedby="B6-ijms-22-09488">6</a>], whereas ATTRwt is an age-related disorder, affecting 20–25% of the population over 80 years, with predominant cardiac phenotype, characterized by wild-type (WT) TTR amyloid deposits [<a href="#B7-ijms-22-09488" class="usa-link" aria-describedby="B7-ijms-22-09488">7</a>,<a href="#B8-ijms-22-09488" class="usa-link" aria-describedby="B8-ijms-22-09488">8</a>].</p>
<p>Despite it is widely accepted that tetramer destabilization is a rate-limiting step for the development of amyloid fibrils [<a href="#B9-ijms-22-09488" class="usa-link" aria-describedby="B9-ijms-22-09488">9</a>,<a href="#B10-ijms-22-09488" class="usa-link" aria-describedby="B10-ijms-22-09488">10</a>,<a href="#B11-ijms-22-09488" class="usa-link" aria-describedby="B11-ijms-22-09488">11</a>,<a href="#B12-ijms-22-09488" class="usa-link" aria-describedby="B12-ijms-22-09488">12</a>], TTR proteolysis has been increasingly recognized as another mechanism driving TTR amyloid formation. Several studies reported the existence of different TTR amyloid deposits in a range of tissues. Thus, amyloid deposits might be composed mainly of full-length TTR (type-B fibrils) or by a mixture of both cleaved and full-length TTR (type-A fibrils) [<a href="#B13-ijms-22-09488" class="usa-link" aria-describedby="B13-ijms-22-09488">13</a>,<a href="#B14-ijms-22-09488" class="usa-link" aria-describedby="B14-ijms-22-09488">14</a>,<a href="#B15-ijms-22-09488" class="usa-link" aria-describedby="B15-ijms-22-09488">15</a>,<a href="#B16-ijms-22-09488" class="usa-link" aria-describedby="B16-ijms-22-09488">16</a>]. Type-A fibrils occur in several tissues, particularly in the heart and are related to the development of restrictive cardiomyopathy after liver transplantation, leading to poor clinical outcomes in ATTR V30M patients [<a href="#B17-ijms-22-09488" class="usa-link" aria-describedby="B17-ijms-22-09488">17</a>]. The protease responsible for TTR cleavage has not yet been identified. However, the specific fragmentation at Lys48 in the TTR polypeptide suggests that it could be a trypsin-like serine protease [<a href="#B18-ijms-22-09488" class="usa-link" aria-describedby="B18-ijms-22-09488">18</a>]. In vitro experiments using recombinant trypsin indicate that several amyloidogenic TTR variants are susceptible to trypsin-mediated proteolysis [<a href="#B19-ijms-22-09488" class="usa-link" aria-describedby="B19-ijms-22-09488">19</a>,<a href="#B20-ijms-22-09488" class="usa-link" aria-describedby="B20-ijms-22-09488">20</a>,<a href="#B21-ijms-22-09488" class="usa-link" aria-describedby="B21-ijms-22-09488">21</a>]. The process of cleavage and release of the 49–127 TTR fragment, the most frequent fragment detected in fibrils, is faster for the highly amyloidogenic variant, TTR S52P, being the 49–127 C-terminal fragment rapidly incorporated into amyloid fibrils [<a href="#B19-ijms-22-09488" class="usa-link" aria-describedby="B19-ijms-22-09488">19</a>,<a href="#B20-ijms-22-09488" class="usa-link" aria-describedby="B20-ijms-22-09488">20</a>].</p>
<p>Additionally, in silico studies pointed out plasmin as a plausible pathophysiological candidate protease involved in the process of TTR amyloid formation [<a href="#B22-ijms-22-09488" class="usa-link" aria-describedby="B22-ijms-22-09488">22</a>]. Furthermore, the ubiquitous distribution of plasmin, its structural similarities to trypsin [<a href="#B22-ijms-22-09488" class="usa-link" aria-describedby="B22-ijms-22-09488">22</a>], and the reported activation of plasminogen activation system (PAS) in other amyloid-related disorders, such as Alzheimer’s disease [<a href="#B23-ijms-22-09488" class="usa-link" aria-describedby="B23-ijms-22-09488">23</a>] and immunoglobulin light chain (AL) amyloidosis [<a href="#B24-ijms-22-09488" class="usa-link" aria-describedby="B24-ijms-22-09488">24</a>,<a href="#B25-ijms-22-09488" class="usa-link" aria-describedby="B25-ijms-22-09488">25</a>,<a href="#B26-ijms-22-09488" class="usa-link" aria-describedby="B26-ijms-22-09488">26</a>] indicate that this protease could have a key role in TTR amyloidogenesis. Indeed, the 49–127 C-terminal TTR fragment was also found in in vitro plasmin-digested TTR S52P samples, suggesting that TTR-digested samples are more prone to aggregate than the non-digested ones [<a href="#B22-ijms-22-09488" class="usa-link" aria-describedby="B22-ijms-22-09488">22</a>].</p>
<p>On the other hand, serine protease inhibitors (Serpins), particularly SerpinA1, have also been related to pathological proteinopathies, such as Alzheimer’s disease [<a href="#B27-ijms-22-09488" class="usa-link" aria-describedby="B27-ijms-22-09488">27</a>,<a href="#B28-ijms-22-09488" class="usa-link" aria-describedby="B28-ijms-22-09488">28</a>,<a href="#B29-ijms-22-09488" class="usa-link" aria-describedby="B29-ijms-22-09488">29</a>]. We hypothesized that SerpinA1 may act as a modulator of TTR proteolysis/fibrillogenesis. SerpinA1 belongs to the clade A serpins, which are classified as antitrypsin-like [<a href="#B30-ijms-22-09488" class="usa-link" aria-describedby="B30-ijms-22-09488">30</a>]. SerpinA1 and also SerpinA3 were found to be differentially expressed in ATTRm patients compared to healthy controls [<a href="#B31-ijms-22-09488" class="usa-link" aria-describedby="B31-ijms-22-09488">31</a>,<a href="#B32-ijms-22-09488" class="usa-link" aria-describedby="B32-ijms-22-09488">32</a>]. The SerpinA1 mRNA was found to be differentially expressed in hepatocyte-like cells (HLCs) from ATTR patients compared to healthy controls and, a high inverse correlation between <em>SerpinA1</em> and <em>TTR</em> genes was also observed. Upon TTR knockdown in HLCs the correlation was abolished [<a href="#B33-ijms-22-09488" class="usa-link" aria-describedby="B33-ijms-22-09488">33</a>]. Recently, it was demonstrated that SerpinA1 knockdown modulates TTR expression in both cellular and animal models, performing an important role in the development of ATTR amyloidosis [<a href="#B34-ijms-22-09488" class="usa-link" aria-describedby="B34-ijms-22-09488">34</a>].</p>
<p>In this study, we further explored the role of SerpinA1 on the in vitro and in vivo modulation of plasmin-mediated TTR proteolysis and how this modulation may impact TTR amyloidogenesis to contribute to the development of more targeted therapies for the treatment of ATTR amyloidosis.</p></section><section id="sec2-ijms-22-09488"><h2 class="pmc_sec_title">2. Results</h2>
<section id="sec2dot1-ijms-22-09488"><h3 class="pmc_sec_title">2.1. SerpinA1 Inhibits In Vitro Plasmin-Mediated Proteolysis of Transthyretin V30M</h3>
<p>Previous studies revealed that similarly to TTR S52P, recombinant TTR V30M was also susceptible to plasmin-mediated proteolysis [<a href="#B22-ijms-22-09488" class="usa-link" aria-describedby="B22-ijms-22-09488">22</a>]. In addition, amyloid deposits extracted from cardiac and adipose tissue specimens from ATTR V30M patients were composed of a mixture of both cleaved and full-length TTR [<a href="#B13-ijms-22-09488" class="usa-link" aria-describedby="B13-ijms-22-09488">13</a>,<a href="#B14-ijms-22-09488" class="usa-link" aria-describedby="B14-ijms-22-09488">14</a>,<a href="#B15-ijms-22-09488" class="usa-link" aria-describedby="B15-ijms-22-09488">15</a>]. Thus, we performed in vitro proteolysis experiments to evaluate whether SerpinA1 performs a role on the inhibition of plasmin-mediated TTR V30M proteolysis. Recombinant TTR V30M was incubated with plasmin at 37 °C for 24 h, and the resulting mixture was analyzed by SDS-PAGE and Western blot. Besides the dimeric (~35 kDa) and monomeric (~17 kDa) TTR V30M forms, Western blotting analysis revealed the presence of two different TTR fragments, in contrast to non-digested samples (<a href="#ijms-22-09488-f001" class="usa-link">Figure 1</a>A and <a href="#app1-ijms-22-09488" class="usa-link">Supplementary data Figure S1</a>). These fragments were detected with the commercially available antibody produced and characterized in our lab [<a href="#B35-ijms-22-09488" class="usa-link" aria-describedby="B35-ijms-22-09488">35</a>], anti-TTR mutant (Y78F), clone AD7 (<a href="#ijms-22-09488-f001" class="usa-link">Figure 1</a>A) but not with rabbit polyclonal anti-TTR from DAKO (<a href="#ijms-22-09488-f001" class="usa-link">Figure 1</a>B).</p>
<figure class="fig xbox font-sm" id="ijms-22-09488-f001"><h4 class="obj_head">Figure 1.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8430710_ijms-22-09488-g001.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec7/8430710/c506f3b53d06/ijms-22-09488-g001.jpg" loading="lazy" height="540" width="788" alt="Figure 1"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-09488-f001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Plasmin cleaves transthyretin V30M, and its activity is inhibited by SerpinA1. Representative images of Western blotting analysis of the three independent in vitro experiments. Western blot was performed using two different antibodies targeting human TTR, mouse anti-TTR mutant (Y78F), clone AD7 (<strong>A</strong>), and rabbit anti-transthyretin (<strong>B</strong>). Both antibodies detected dimeric and monomeric TTR forms. However, only the mouse anti-TTR mutant (Y78F) clone AD7 detects TTR fragments (<strong>A</strong>).</p></figcaption></figure><p>N-terminal sequencing analysis of the TTR fragments firstly observed in Western blotting analysis indicates that band 1 corresponds to a peptide starting at position 49 and band 2 to a peptide starting at the first amino acid of TTR polypeptide chain (<a href="#ijms-22-09488-t001" class="usa-link">Table 1</a>). Furthermore, the bands corresponding to TTR fragments were excised from SDS-PAGE gels and further analyzed by mass spectrometry (MS) analysis after trypsin digestion. These MS experiments revealed that band 1 was composed of the peptides with mass corresponding to the amino acids 81–103, 104–127, 105–126, and 105–127 (<a href="#app1-ijms-22-09488" class="usa-link">Table S1</a>), which along with N-terminal sequencing data, indicated that band 1 should correspond to the TTR fragment 49–127 (<a href="#ijms-22-09488-t001" class="usa-link">Table 1</a>). Band 2 was composed by the peptides with mass corresponding to the amino acids 1–15, 22–34, 35–48, and 36–48 (<a href="#app1-ijms-22-09488" class="usa-link">Table S1</a>). Together with N-terminal sequencing data, our results indicate that band 2 was the TTR fragment 1–48 (<a href="#ijms-22-09488-t001" class="usa-link">Table 1</a>). Intriguingly, the band containing 1–48 N-terminal TTR fragment also revealed the presence of a C-terminal peptide comprising the amino acids 105–127. Since the number of peptide-spectrum matches (PSMs) identified for that peptide group was only two, which was too low compared to the N-terminal peptides, this might indicate that this C-terminal peptide 105–127 was a contaminant.</p>
<section class="tw xbox font-sm" id="ijms-22-09488-t001"><h4 class="obj_head">Table 1.</h4>
<div class="caption p"><p>Identification of transthyretin peptides upon plasmin digestion by N-terminal sequencing. Band 1 starts at the amino acid residue 49, whereas band 2 starts at the first amino acid residue in the transthyretin polypeptide chain, indicating that band 1 corresponds to the 49–127 C-terminal fragment and band 2 to the 1–48 N-terminal fragment.</p></div>
<div class="tbl-box p" tabindex="0"><table class="content" frame="hsides" rules="groups">
<thead>
<tr>
<th rowspan="2" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" colspan="1">TTR Fragment</th>
<th colspan="5" align="center" valign="middle" style="border-top:solid thin;border-bottom:solid thin" rowspan="1">Residue Number</th>
</tr>
<tr>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">1</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">2</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">3</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">4</th>
<th align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">5</th>
</tr>
</thead>
<tbody>
<tr>
<td align="center" valign="middle" rowspan="1" colspan="1">#1</td>
<td align="center" valign="middle" rowspan="1" colspan="1">T</td>
<td align="center" valign="middle" rowspan="1" colspan="1">S</td>
<td align="center" valign="middle" rowspan="1" colspan="1">E</td>
<td align="center" valign="middle" rowspan="1" colspan="1">S</td>
<td align="center" valign="middle" rowspan="1" colspan="1">G</td>
</tr>
<tr>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">#2</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">P</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">G</td>
<td align="center" valign="middle" style="border-bottom:solid thin" rowspan="1" colspan="1">T</td>
</tr>
</tbody>
</table></div>
<div class="p text-right font-secondary"><a href="table/ijms-22-09488-t001/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div></section><p>Following, we investigated the role of the serine protease inhibitor, SerpinA1, as a modulator of plasmin-mediated TTR proteolysis. We found that TTR proteolysis was partially inhibited in the presence of SerpinA1 (<a href="#ijms-22-09488-f001" class="usa-link">Figure 1</a>A and <a href="#app1-ijms-22-09488" class="usa-link">Figure S1</a>). No TTR fragments were observed neither before the assay nor in the absence of plasmin, excluding the influence of TTR auto-proteolysis or degradation. In opposition to TTR V30M, TTR WT was not susceptible to plasmin-mediated proteolysis under the same conditions as presented in <a href="#app1-ijms-22-09488" class="usa-link">supplementary data (Figure S2</a>).</p></section><section id="sec2dot2-ijms-22-09488"><h3 class="pmc_sec_title">2.2. SerpinA1 Inhibits In Vitro Transthyretin V30M Aggregation upon Plasmin-Mediated Proteolysis</h3>
<p>The presence of TTR fragments, particularly the 49–127 C-terminal peptide, was implicated in TTR amyloidogenesis. Studies of in vitro TTR cleavage indicated that this fragment generated upon digestion with trypsin or plasmin was rapidly incorporated into amyloid fibrils, suggesting that TTR proteolysis facilitated the process of TTR aggregation [<a href="#B19-ijms-22-09488" class="usa-link" aria-describedby="B19-ijms-22-09488">19</a>,<a href="#B20-ijms-22-09488" class="usa-link" aria-describedby="B20-ijms-22-09488">20</a>,<a href="#B21-ijms-22-09488" class="usa-link" aria-describedby="B21-ijms-22-09488">21</a>,<a href="#B22-ijms-22-09488" class="usa-link" aria-describedby="B22-ijms-22-09488">22</a>]. Similarly, in the present work, we investigated the influence of plasmin-mediated proteolysis on the aggregation potential of TTR V30M. Upon 24 h of incubation, both plasmin-digested and non-digested samples were characterized using dynamic light scattering (DLS) analysis (<a href="#ijms-22-09488-f002" class="usa-link">Figure 2</a>). Plasmin-mediated proteolysis facilitates the process of TTR aggregation, as observed by the increase of TTR aggregated species (909.7 nm; 8.1%) along with the decrease of the soluble form (13.15 nm; 75.4%) (<a href="#ijms-22-09488-f002" class="usa-link">Figure 2</a>B), comparatively to non-digested samples, in which TTR was only found in the soluble form (9.228 nm; 98.5%) (<a href="#ijms-22-09488-f002" class="usa-link">Figure 2</a>A). In addition, TTR V30M incubated with SerpinA1 revealed the presence of soluble particles exhibiting a large diameter (23.81 nm, 100%) (<a href="#ijms-22-09488-f002" class="usa-link">Figure 2</a>C), probably indicating the formation of TTR-SerpinA1 complex, as described previously [<a href="#B33-ijms-22-09488" class="usa-link" aria-describedby="B33-ijms-22-09488">33</a>]. Samples incubated with both plasmin and SerpinA1 presented less abundant and smaller TTR aggregates (537.7 nm; 4.3%) (<a href="#ijms-22-09488-f002" class="usa-link">Figure 2</a>D), as compared to samples only incubated with plasmin (<a href="#ijms-22-09488-f002" class="usa-link">Figure 2</a>B).</p>
<figure class="fig xbox font-sm" id="ijms-22-09488-f002"><h4 class="obj_head">Figure 2.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8430710_ijms-22-09488-g002.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec7/8430710/37a8e0525d2b/ijms-22-09488-g002.jpg" loading="lazy" height="412" width="785" alt="Figure 2"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-09488-f002/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Plasmin enhances the transthyretin V30M aggregation, while SerpinA1 inhibits the process. Dynamic light scattering analysis was performed upon transthyretin V30M incubation at 37 °C for 24 h: (<strong>A</strong>) alone; (<strong>B</strong>) with plasmin; (<strong>C</strong>) with SerpinA1; (<strong>D</strong>) with plasmin and SerpinA1. The data results from three independent in vitro experiments, each one performed in triplicate.</p></figcaption></figure><p>Besides its function as a serine protease inhibitor, SerpinA1 also functions as an extracellular chaperone and recently, it was reported that SerpinA1 inhibited TTR amyloid formation in vitro [<a href="#B33-ijms-22-09488" class="usa-link" aria-describedby="B33-ijms-22-09488">33</a>]. Thus, the same samples were analyzed by thioflavin T (ThT) assays to evaluate the amyloid nature of the formed species. The results demonstrated that plasmin facilitates TTR V30M amyloid formation, as observed by the increased ThT emission fluorescence signals upon plasmin incubation (1086 ± 75.68 vs. 901.3 ± 91.88 in the absence of plasmin) (<a href="#ijms-22-09488-f003" class="usa-link">Figure 3</a>). Moreover, in the presence of plasmin, TTR V30M amyloid formation was significantly inhibited by SerpinA1 (510 ± 60.58 vs. 1086 ± 75.68 in the absence of SerpinA1; <em>p</em> &lt; 0.05). SerpinA1 per se seemed to inhibit TTR V30M amyloid formation (613 ± 134 vs. 901.3 ± 91.88 in the absence of SerpinA1) (<a href="#ijms-22-09488-f003" class="usa-link">Figure 3</a>).</p>
<figure class="fig xbox font-sm" id="ijms-22-09488-f003"><h4 class="obj_head">Figure 3.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8430710_ijms-22-09488-g003.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec7/8430710/b9acfb5ff317/ijms-22-09488-g003.jpg" loading="lazy" height="454" width="738" alt="Figure 3"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-09488-f003/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Transthyretin amyloid formation is favored upon plasmin-mediated proteolysis, being partially inhibited by SerpinA1. Thioflavin T experiments were performed upon transthyretin V30M incubation with plasmin and/or SerpinA1, at 37 °C for 24h. The fluorescence emission signal of thioflavin T of transthyretin V30M at the beginning of the experiment (T = 0 h) is represented as the red dotted line around 607. The data results from three independent in vitro experiments (<em>n</em> = 3). Statistical analysis was performed using one-way ANOVA with Tukey’s multiple comparison as post-test. * <em>p</em> &lt; 0.05 in the presence of plasmin/presence of SerpinA1 vs. presence of plasmin/absence of SerpinA1, q = 6.092, df = 3. Effect size (r) = 0.924, odds ratio = 0.69 for an interval of confidence of 95%.</p></figcaption></figure></section><section id="sec2dot3-ijms-22-09488"><h3 class="pmc_sec_title">2.3. SerpinA1 Downregulation Increased Transthyretin Deposition in the Heart of Old Transgenic Mice Carrying Human Transthyretin V30M Mutation</h3>
<p>Previous studies reported that SerpinA1 knockdown was accompanied by an increase in TTR mRNA expression, as well as TTR protein levels in HepG2 cells. In collaboration with our group, it was also reported that SerpinA1 knockdown resulted in an increase in TTR mRNA expression in mouse liver, as well as in TTR protein levels in plasmas of transgenic mice carrying human TTR V30M mutation (HM30) [<a href="#B34-ijms-22-09488" class="usa-link" aria-describedby="B34-ijms-22-09488">34</a>]. Therefore, we decided to investigate whether SerpinA1 was also specifically downregulated in the mouse heart and whether effects on TTR protein levels could be observed. For that, SerpinA1-specific ASOs were subcutaneously administered to HM30 mice once a week for six weeks. Western blotting analysis (<a href="#ijms-22-09488-f004" class="usa-link">Figure 4</a>A–C), as well as immunohistochemistry (<a href="#ijms-22-09488-f004" class="usa-link">Figure 4</a>D), confirmed that SerpinA1 was effectively downregulated in the heart from younger and older animals (0.018 ± 0.01 vs. 1.0 ± 0.18 in ASO-CTR, <em>p</em> &lt; 0.0001). In addition, a significant increase in TTR protein in mice cardiac tissue was observed (1.6 ± 0.18 vs. 1.0 ± 0.14 in ASO-CTR group, <em>p</em> = 0.020) (<a href="#ijms-22-09488-f004" class="usa-link">Figure 4</a>E–G).</p>
<figure class="fig xbox font-sm" id="ijms-22-09488-f004"><h4 class="obj_head">Figure 4.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8430710_ijms-22-09488-g004.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec7/8430710/07571cd67572/ijms-22-09488-g004.jpg" loading="lazy" height="1091" width="774" alt="Figure 4"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-09488-f004/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Human transthyretin was found to be increased in the heart of transgenic mice carrying human transthyretin V30M mutation upon SerpinA1 downregulation. Western blotting analysis of SerpinA1 and GAPDH expression in the heart of old (16–21 months, <em>n</em> = 7) (<strong>A</strong>) and young (12–13 months, <em>n</em> = 12) (<strong>B</strong>) mice. Quantification of SerpinA1 expression normalized to GAPDH (loading control protein) of the two pooled experiments (<strong>C</strong>). Immunohistochemistry data also reveal that SerpinA1 was effectively downregulated in the heart of HM30 mice. Images were captured at 10× magnification using Olympus BX50 microscope. Scale bar = 20 μm (<strong>D</strong>). Western blotting of TTR and GAPDH expression in mice cardiac tissue of both old (<strong>E</strong>) and young (<strong>F</strong>) animals. Bar plot represents the quantification of transthyretin expression normalized to GAPDH of the two pooled in vivo experiments (<strong>G</strong>). Protein bands were quantified by densitometry using Image J. Statistical analysis was performed using an unpaired <em>t</em>-test. *** <em>p</em> &lt; 0.0001 when comparing the SerpinA1/GAPDH ratio between ASO-CTR and mA1AT-ASO, t = 6.026, df = 17; * <em>p</em> &lt; 0.05 when comparing the hTTR/GAPDH ratio between ASO-CTR and mA1AT-ASO, t = 2.554, df = 17. Calculations were performed for an interval of confidence of 95%.</p></figcaption></figure><p>Our previous data revealed that, along with increased TTR mRNA and protein levels, SerpinA1 knockdown increased in vivo TTR deposition in several tissues, such as dorsal root ganglia (DRGs) and intestine [<a href="#B34-ijms-22-09488" class="usa-link" aria-describedby="B34-ijms-22-09488">34</a>]. In this study, we addressed whether TTR deposition was also promoted in mouse cardiac tissue after SerpinA1 downregulation. In younger animals, duodenal TTR deposition was found to be increased upon silencing of SerpinA1 (1.773 ± 0.94 vs. 0.1951 ± 0.04 in ASO-CTR, <em>p</em> = 0.0087) (<a href="#ijms-22-09488-f005" class="usa-link">Figure 5</a>, upper panel), and a similar tendency was also observed in older animals (<a href="#ijms-22-09488-f005" class="usa-link">Figure 5</a>, lower panel). Additionally, immunohistochemistry analysis demonstrated that TTR deposition was favored in the heart of older animals upon SerpinA1 downregulation (8.307 ± 0.6697 vs. 3.049 ± 1.269 in ASO-CTR, <em>p</em> = 0.0106) (<a href="#ijms-22-09488-f005" class="usa-link">Figure 5</a>, lower panel), comparatively to the younger group (<a href="#ijms-22-09488-f005" class="usa-link">Figure 5</a>, upper panel).</p>
<figure class="fig xbox font-sm" id="ijms-22-09488-f005"><h4 class="obj_head">Figure 5.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8430710_ijms-22-09488-g005.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec7/8430710/8aea1335fc22/ijms-22-09488-g005.jpg" loading="lazy" height="1641" width="726" alt="Figure 5"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-09488-f005/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Transthyretin deposition is increased upon SerpinA1 knockdown in the mouse heart of older animals. Representative images of immunohistochemical analysis of mouse heart and duodenum upon the administration of antisense oligonucleotides targeting SerpinA1 to young (12–13 months, <em>n</em> = 12) (upper panel) and old (16–21 months, <em>n</em> = 7) (lower panel) animals. Bar plot representation of TTR quantification normalized to the total occupied area in the duodenum (<strong>A</strong>,<strong>C</strong>) and heart (<strong>B</strong>,<strong>D</strong>) of young (<strong>A</strong>,<strong>B</strong>) and old (<strong>C</strong>,<strong>D</strong>) mice. Images were captured at 10× magnification using Olympus BX50 microscope and analyzed using Image Pro Plus software. Scale bar = 20 μm. Statistical analysis was performed using an unpaired <em>t</em>-test. ** <em>p</em> &lt; 0.01 comparing TTR deposition in the duodenum of younger animals in ASO-CTR vs. mA1AT-ASO, t = 3.300, df = 10; * <em>p</em> &lt; 0.05 comparing TTR deposition in the heart of younger animals in ASO-CTR vs. mA1AT-ASO, t = 3.969, df = 5. Calculations were performed for an interval of confidence of 95%.</p></figcaption></figure></section><section id="sec2dot4-ijms-22-09488"><h3 class="pmc_sec_title">2.4. Transthyretin Fragments Are Observed in Mouse Cardiac Tissue upon SerpinA1 Downregulation</h3>
<p>Based on our experiments of in vitro plasmin-mediated proteolysis described above, indicating that SerpinA1 inhibits TTR cleavage, we evaluated the impact of SerpinA1 knockdown on TTR cleavage in vivo. Western blotting analysis revealed the presence of a protein band below to the monomeric TTR, corresponding to TTR fragment (&lt;11 kDa) in mouse cardiac tissue in younger (<a href="#ijms-22-09488-f006" class="usa-link">Figure 6</a>A) and older animals (<a href="#ijms-22-09488-f006" class="usa-link">Figure 6</a>B). Similarly, these fragments were only detected using the antibody anti-TTR mutant (Y78F), clone AD7. In opposition, no TTR fragments were found upon SerpinA1 knockdown neither in other tissues of TTR deposition, such as duodenum (<a href="#app1-ijms-22-09488" class="usa-link">Supplementary data Figure S4A</a>) and stomach (<a href="#app1-ijms-22-09488" class="usa-link">Supplementary data Figure S4B</a>) nor in mice plasmas (<a href="#app1-ijms-22-09488" class="usa-link">Supplementary data Figure S4C</a>).</p>
<figure class="fig xbox font-sm" id="ijms-22-09488-f006"><h4 class="obj_head">Figure 6.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8430710_ijms-22-09488-g006.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec7/8430710/32961bcf840a/ijms-22-09488-g006.jpg" loading="lazy" height="549" width="716" alt="Figure 6"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-09488-f006/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Western blotting analysis revealed the presence of transthyretin fragments upon SerpinA1 downregulation in the heart. Transthyretin fragments were detected in the heart of both older (<strong>A</strong>) and younger (<strong>B</strong>) animals.</p></figcaption></figure></section><section id="sec2dot5-ijms-22-09488"><h3 class="pmc_sec_title">2.5. SerpinA1 Downregulation Increases Proteolytic Activity, Particularly Plasmin Activity, in Plasmas of Transgenic Mice Carrying Human Transthyretin V30M Mutation</h3>
<p>SerpinA1 partially inhibits plasmin-mediated proteolysis in vitro. Thus, fluorescence-based enzymatic assays were performed to evaluate the effects of downregulation of SerpinA1 on serine protease activity, namely plasmin activity in vivo. In fact, serine protease activity was effectively increased in plasmas of HM30 mice upon SerpinA1 downregulation (12.69 ± 1.746 vs. 9.606 ± 1.675 in ASO-CTR, <em>p</em> = 0.046) (<a href="#ijms-22-09488-f007" class="usa-link">Figure 7</a>A) while no proteolytic activity was found in mice heart homogenates (<a href="#app1-ijms-22-09488" class="usa-link">Figure S5</a>). In particular, the activity of plasmin was also found to be increased in mice plasmas after SerpinA1 knockdown (8422 ± 432 vs. 7013 ± 458 in ASO-CTR, <em>p</em> = 0.040) (<a href="#ijms-22-09488-f007" class="usa-link">Figure 7</a>B).</p>
<figure class="fig xbox font-sm" id="ijms-22-09488-f007"><h4 class="obj_head">Figure 7.</h4>
<p class="img-box line-height-none margin-x-neg-2 tablet:margin-x-0 text-center"><a class="tileshop" target="_blank" href="https://www.ncbi.nlm.nih.gov/core/lw/2.0/html/tileshop_pmc/tileshop_pmc_inline.html?title=Click%20on%20image%20to%20zoom&amp;p=PMC3&amp;id=8430710_ijms-22-09488-g007.jpg"><img class="graphic zoom-in" src="https://cdn.ncbi.nlm.nih.gov/pmc/blobs/cec7/8430710/62fc70ecc180/ijms-22-09488-g007.jpg" loading="lazy" height="349" width="793" alt="Figure 7"></a></p>
<div class="p text-right font-secondary"><a href="figure/ijms-22-09488-f007/" class="usa-link" target="_blank" rel="noopener noreferrer">Open in a new tab</a></div>
<figcaption><p>Serine protease activity and, particularly plasmin activity was found to be increased in mice plasmas upon SerpinA1 knockdown. Serine protease activity (<strong>A</strong>) and plasmin activity (<strong>B</strong>) were measured in plasma samples of HM30 mice according to the manufacturer’s instructions. Statistical analysis was performed using an unpaired <em>t</em>-test. * <em>p</em> &lt; 0.05 comparing protease activity between ASO-CTR and mA1AT-ASO, t = 2.189, df = 14; * <em>p</em> &lt; 0.05 comparing plasmin activity between ASO-CTR and mA1AT-ASO, t = 2.235, df = 16. Calculations were performed for an interval of confidence of 95%.</p></figcaption></figure></section></section><section id="sec3-ijms-22-09488"><h2 class="pmc_sec_title">3. Discussion</h2>
<p>Tetramer destabilization is considered the rate-limiting step driving TTR amyloidogenesis. However, TTR proteolysis has been reported as an additional mechanism contributing to TTR amyloid formation [<a href="#B36-ijms-22-09488" class="usa-link" aria-describedby="B36-ijms-22-09488">36</a>]. The 49–127 C-terminal fragment is the most frequently encountered in ex vivo amyloid fibrils [<a href="#B13-ijms-22-09488" class="usa-link" aria-describedby="B13-ijms-22-09488">13</a>,<a href="#B15-ijms-22-09488" class="usa-link" aria-describedby="B15-ijms-22-09488">15</a>], and, the fragmentation pattern at Lys residues indicates the activity of a trypsin-like serine protease [<a href="#B18-ijms-22-09488" class="usa-link" aria-describedby="B18-ijms-22-09488">18</a>,<a href="#B37-ijms-22-09488" class="usa-link" aria-describedby="B37-ijms-22-09488">37</a>].</p>
<p>Bellotti and collaborators identified three TTR fragments upon in vitro incubation of the highly amyloidogenic TTR S52P with trypsin, being the 49–127 C-terminal fragment more prone to aggregation than the 16–127 and 81–127 C-terminal fragments [<a href="#B19-ijms-22-09488" class="usa-link" aria-describedby="B19-ijms-22-09488">19</a>]. A similar pattern of fragmentation was obtained with plasmin, a ubiquitous, widely distributed serine protease related to fibrinolysis [<a href="#B22-ijms-22-09488" class="usa-link" aria-describedby="B22-ijms-22-09488">22</a>].</p>
<p>Recently, the serine protease inhibitor, SerpinA1, was implicated in ATTR amyloidogenesis, and we hypothesized that it could also modulate TTR proteolysis. Previous studies by Niemietz et al. demonstrated that SerpinA1 inhibited TTR aggregation both in vitro, in cell culture experiments using hepatocyte-like cells (HLCs), and in vivo, in a study of SerpinA1 knockdown in mice carrying human TTR V30M mutation (HM30) [<a href="#B33-ijms-22-09488" class="usa-link" aria-describedby="B33-ijms-22-09488">33</a>,<a href="#B34-ijms-22-09488" class="usa-link" aria-describedby="B34-ijms-22-09488">34</a>].</p>
<p>In this study, our aim was to investigate the role of SerpinA1 as an inhibitor of serine proteases and its effect on the in vitro and in vivo modulation of TTR amyloid formation to contribute to a better knowledge of the process and to search for new and more specific therapeutic approaches.</p>
<p>In this sense, we confirmed that TTR V30M, the most frequent TTR variant related to ATTR amyloidosis, was prone to plasmin-mediated proteolysis in vitro and, that the cleaved protein aggregates more rapidly than the non-cleaved TTR V30M. N-terminal sequencing and MS analysis of the bands corresponding to TTR fragments generated by plasmin-mediated proteolysis identified the presence of the peptides 1–48 N-terminal and 49–127 C-terminal. The N-terminal region of the TTR polypeptide chain was enriched in hydrophobic amino acid residues and, importantly, the 26–57 TTR segment, belonging to the aggregation-prone regions (APR), exhibited high amyloid propensity [<a href="#B18-ijms-22-09488" class="usa-link" aria-describedby="B18-ijms-22-09488">18</a>]. These APR were protected when the protein was in its native form [<a href="#B38-ijms-22-09488" class="usa-link" aria-describedby="B38-ijms-22-09488">38</a>]. However, the destabilization of the native TTR structure induced by the single-point mutation at position 30 might expose those regions to cleavage, and, for that, the fragment 1–48 N-terminal TTR fragment may also be potentially considered highly amyloidogenic. It has been demonstrated that the 49–127 C-terminal fragment facilitates TTR amyloid formation in vitro [<a href="#B19-ijms-22-09488" class="usa-link" aria-describedby="B19-ijms-22-09488">19</a>,<a href="#B20-ijms-22-09488" class="usa-link" aria-describedby="B20-ijms-22-09488">20</a>,<a href="#B21-ijms-22-09488" class="usa-link" aria-describedby="B21-ijms-22-09488">21</a>,<a href="#B22-ijms-22-09488" class="usa-link" aria-describedby="B22-ijms-22-09488">22</a>], and, accordingly, Dasari et al. recently determined that the proteolytic cleavage of the K48-T49 peptide bond in the CD loop accelerated the formation of small spherical oligomers, which exhibited cytotoxic effects in neuroblastoma SH-SY5Y cells [<a href="#B39-ijms-22-09488" class="usa-link" aria-describedby="B39-ijms-22-09488">39</a>]. It was also shown that TTR aggregates generated by full-length or truncated TTR forms exhibited nearly identical molecular structural features, suggesting that TTR proteolysis in the CD loop destabilizes the native TTR tetramer. This destabilization of the TTR tetramer promotes oligomer formation through a similar mechanism of TTR misfolding and aggregation rather than through another molecular mechanism [<a href="#B39-ijms-22-09488" class="usa-link" aria-describedby="B39-ijms-22-09488">39</a>].</p>
<p>Marcoux et al. suggested the influence of biomechanical forces, particularly shear stress forces generated by fluid flow, on TTR proteolysis, which could influence the tissue specificity of TTR amyloid deposition. Indeed, a mechano-enzymatic cleavage mechanism for TTR proteolysis was proposed, where tetrameric TTR might be cleaved prior to TTR deposition and, then, due to strong shear stress observed in the heart, the C-terminal fragments would be released being rapidly incorporated into amyloid fibrils. Alternatively, both cleavage and dissociation may occur simultaneously at the heart, where both local shear stress forces and the relevant protease could be present [<a href="#B20-ijms-22-09488" class="usa-link" aria-describedby="B20-ijms-22-09488">20</a>]. These shear and interfacial forces are particularly strong in the cardiac tissue [<a href="#B40-ijms-22-09488" class="usa-link" aria-describedby="B40-ijms-22-09488">40</a>], which might explain the frequently encountered type-A fibrils in TTR deposits found in the heart. However, the presence of type-A amyloid fibrils in other tissues, such as the vitreous humor and the spinal cord of ATTR V30M patients, indicate that this mechanism would not explain the formation of TTR amyloid deposits based on their tissue-specific location, since these shear stress conditions were not observed neither in the eye nor in the central nervous system [<a href="#B41-ijms-22-09488" class="usa-link" aria-describedby="B41-ijms-22-09488">41</a>,<a href="#B42-ijms-22-09488" class="usa-link" aria-describedby="B42-ijms-22-09488">42</a>,<a href="#B43-ijms-22-09488" class="usa-link" aria-describedby="B43-ijms-22-09488">43</a>]. Moreover, in a recent study of Suhr et al., 14 out of 15 families with ATTR V30M amyloidosis exhibited a similar amyloid fibril composition within family members, independently of the age-onset disease. These observations indicate that, besides specific tissue/organ characteristics, genetic and/or epigenetic alterations may influence the amyloid fibril composition [<a href="#B44-ijms-22-09488" class="usa-link" aria-describedby="B44-ijms-22-09488">44</a>].</p>
<p>Our in vitro results using recombinant TTR show that SerpinA1 partially inhibits plasmin-mediated TTR proteolysis and suggest that, in parallel, it can also have an effect on the inhibition of TTR V30M amyloid formation seem to be independent of the presence of plasmin. Interestingly, this effect was compatible with the physical interaction between SerpinA1 and TTR that was recently suggested [<a href="#B33-ijms-22-09488" class="usa-link" aria-describedby="B33-ijms-22-09488">33</a>]. In addition, our DLS data indicate the presence of large diameter soluble particles, possibly the SerpinA1-TTR complex. Thus, future studies should be performed to clarify whether SerpinA1 performs an important role as a modulator of TTR proteolysis through its interaction with TTR, avoiding the access of plasmin to its targeting region in the TTR structure.</p>
<p>Our previous studies of SerpinA1 downregulation showed significantly increased TTR serum levels in HM30 mice, as well as in hepatoma cells [<a href="#B34-ijms-22-09488" class="usa-link" aria-describedby="B34-ijms-22-09488">34</a>]. Furthermore, SerpinA1 knockdown led to increased TTR deposition in the gastrointestinal tract, as well as in the sciatic nerve and dorsal root ganglia (DRG) of HM30 mice. In this work, we also found increased TTR protein deposits in the heart of older HM30 mice, whereas increased duodenal TTR deposition was found in the younger mice and, the same tendency was also observed in older ages. Moreover, we detected TTR fragments in mouse cardiac tissue upon SerpinA1 downregulation, while no TTR fragments were detected in mice plasmas nor in deposits from other tissues, such as the duodenum and stomach. The absence of fragments in mice plasmas upon SerpinA1 knockdown, as revealed in AD7 immunoblot, might be related to a very low concentration of TTR fragments in plasma and/or to insufficient sensitivity of the method. Additionally, we found increased serine protease activity, particularly plasmin activity, in plasmas upon treatment with ASOs targeting SerpinA1, whereas no proteolytic activity was observed in the heart of HM30 mice (<a href="#app1-ijms-22-09488" class="usa-link">Figure S3</a>).</p>
<p>Despite the increasing interest in TTR proteolysis as a leading mechanism-driving TTR amyloidosis, some questions remain to be answered, namely whether TTR fragmentation occurs, prior to or after TTR aggregation/deposition and where it occurs. Some authors reported that plasmin degrades amorphous protein aggregates, releasing smaller soluble protein fragments, which were cytotoxic to both endothelial and microglial cells [<a href="#B45-ijms-22-09488" class="usa-link" aria-describedby="B45-ijms-22-09488">45</a>]. Trypsin or trypsin-like enzymes directly cleave acid-induced aggregates of full-length TTR V30M and barely cleave native soluble TTR V30M tetramer [<a href="#B46-ijms-22-09488" class="usa-link" aria-describedby="B46-ijms-22-09488">46</a>]. Additionally, recent cryo-electron microscopy (cryo-EM) experiments revealed the co-existence of both N-terminal and C-terminal TTR segments in one TTR fibril and, the relative special arrangement of these two segments are compatible with full-length TTR, suggesting that the process of fibril formation precedes TTR proteolysis [<a href="#B47-ijms-22-09488" class="usa-link" aria-describedby="B47-ijms-22-09488">47</a>]. In opposition, other studies showed increased proteolytic activity in plasmas from ATTR patients compared to healthy controls, suggesting that TTR proteolysis occurs in the bloodstream prior to TTR aggregation/deposition [<a href="#B31-ijms-22-09488" class="usa-link" aria-describedby="B31-ijms-22-09488">31</a>]. Accordingly, our data demonstrating increased protease and plasmin activity in mice plasmas, along with the absence of protease activity in mice hearts, suggest that in vivo TTR proteolysis occurs before fibril formation (<a href="#ijms-22-09488-f007" class="usa-link">Figure 7</a>A,B, and <a href="#app1-ijms-22-09488" class="usa-link">supplementary data Figure S5</a>).</p>
<p>In summary, our in vitro experiments demonstrate that plasmin cleaves the recombinant TTR V30M proteolytically and promotes its aggregation in vitro. Additionally, SerpinA1 partially inhibits the activity of plasmin in vitro, which decreases TTR amyloid formation. To investigate the relevance of these findings in vivo, SerpinA1 expression was knockdown in HM30 mice. The absence of SerpinA1 favored TTR deposition in mice tissues and increased the serine protease activity, namely plasmin activity in mice plasmas, which was accompanied by the presence of TTR fragments in the mice heart.</p>
<p>This work presents some limitations in particular concerning the knowledge of the detailed mechanism involving SerpinA1 inhibition of plasmin-mediated TTR proteolysis and also the impact of SerpinA1 downregulation in mice carrying TTR WT or carrying non-V30M TTR mutations. Accordingly, future experiments must be performed namely to dissect the molecular mechanisms by which SerpinA1 inhibits plasmin activity through direct interaction with the protease or by the formation of TTR-SerpinA1 complex. Additionally, it would also be interesting to evaluate the role of plasmin on TTR proteolysis using different animal models developing ATTR amyloidosis, such as transgenic mice carrying human A97S mutation [<a href="#B48-ijms-22-09488" class="usa-link" aria-describedby="B48-ijms-22-09488">48</a>]. Ultimately, it is important, to investigate plasmin and other extracellular serine proteases activity in TTR V30M patients and patients carrying other TTR amyloidogenic mutations to evaluate whether this activity has tissue-specific effects or is related to disease progression potentiating its interest as a biomarker in ATTR amyloidosis.</p>
<p>Altogether our in vitro and in vivo results show that plasmin is a plausible protease performing a role on TTR proteolysis and reveal SerpinA1 as an important modulator of the process of TTR cleavage. Our findings might contribute to the development of more effective and targeted therapies for the treatment of ATTR amyloidosis.</p></section><section id="sec4-ijms-22-09488"><h2 class="pmc_sec_title">4. Materials and Methods</h2>
<section id="sec4dot1-ijms-22-09488"><h3 class="pmc_sec_title">4.1. Reagents</h3>
<p>Native human plasmin protein (active), native human SerpinA1 protein (active), protease activity assay kit, plasmin activity assay kit, and recombinant rabbit anti-GAPDH antibody were purchased from Abcam (Cambridge, UK). Mouse monoclonal antibody anti-TTR mutant (Y78F), clone AD7 was from Merck Millipore (Sigma-Merck, Darmstadt, Germany). Rabbit polyclonal anti-human TTR antibody was from DAKO (Hovedstaden, Denmark). Rat monoclonal anti-mouse SerpinA1 antibody was from R&amp;D systems (Minneapolis, MN, USA). Pierce TM High Capacity Endotoxin Removal Resin was from Thermo Scientific (Waltham, MA, USA). GalNAc-AAT ASO (mA1AT-ASO: ACCCAATTCAGAAGGAAGGA) and GalNAc-Control ASO (ASO-CTR: CCTTCCCTGAAGGTTCCTCC) [<a href="#B48-ijms-22-09488" class="usa-link" aria-describedby="B48-ijms-22-09488">48</a>] were kindly provided by Ionis Pharmaceuticals (Carlsbad, CA, USA).</p></section><section id="sec4dot2-ijms-22-09488"><h3 class="pmc_sec_title">4.2. Recombinant Human Transthyretin</h3>
<p>TTR V30M and TTR WT were produced using a bacterial expression system and purified as previously described [<a href="#B49-ijms-22-09488" class="usa-link" aria-describedby="B49-ijms-22-09488">49</a>]. Recombinant TTR was applied to an affinity chromatography column packed with Pierce TM High Capacity Endotoxin Removal to remove bacterial lipopolysaccharides according to the manufacturer’s instructions. TTR was then dialyzed against endotoxin-free phosphate-buffered saline (PBS) (Sigma-Merck, Darmstadt, Germany), concentrated using Vivaspin ultrafiltration units (GE Healthcare, Chicago, IL, USA), and quantified using Bradford protein assay (Bio-Rad, Hercules, CA, USA).</p></section><section id="sec4dot3-ijms-22-09488"><h3 class="pmc_sec_title">4.3. In Vitro Plasmin-Mediated Proteolysis Assays</h3>
<p>TTR variants were firstly filtered through a sterile 0.2 μm inorganic membrane ANOTOP syringe filter (Whatman, Maidstone, UK) to remove any protein aggregates. Then, TTR (18 μM) was incubated with plasmin (0.4U) and/or SerpinA1 (2.8 μM) at 37 °C for 24 h, under stagnant conditions. TTR proteolysis was stopped by using phenylmethylsulfonyl fluoride (PMSF) at a final concentration of 1.5 mM and, then TTR samples (500 ng/well) were applied into a 15% polyacrylamide SDS-PAGE. After electrophoresis, proteins were stained with PageBlue™ protein staining solution (Thermo Scientific, Waltham, MA, USA) or transferred onto nitrocellulose membrane using iBlot dry blotting system (Thermo Scientific, Waltham, MA, USA). TTR immunoblot was performed using a commercially available antibody produced in our lab, mouse anti-transthyretin mutant (Y78F), clone AD7 (1:100) (Sigma-Merck, Darmstadt, Germany). This monoclonal antibody detects glycosylated form of TTR V30M in plasma and acts as a conformational antibody recognizing specific TTR variants, such as G47A, G49A, S50R, and T59K, in particular conditions [<a href="#B28-ijms-22-09488" class="usa-link" aria-describedby="B28-ijms-22-09488">28</a>]. Rabbit polyclonal anti-human TTR (1:1000) (DAKO, Hovedstaden, Denmark) was also used. ECL chemiluminescent reagent (Bio-Rad, Hercules, CA, USA) was used as a detection method using Chemidoc apparatus (Bio-Rad, Hercules, CA, USA). Three independent experiments of in vitro plasmin-mediated proteolysis were performed.</p></section><section id="sec4dot4-ijms-22-09488"><h3 class="pmc_sec_title">4.4. N-Terminal Sequencing Analysis of TTR Fragments</h3>
<p>Plasmin-digested TTR V30M samples (15 μg) were loaded into a 15% polyacrylamide SDS-PAGE gel. Samples were then transferred onto a PVDF membrane (Bio-Rad, Hercules, CA, USA) and proteins were further stained with Coomassie blue R-250 (VWR International, Radnor, PA, USA). Membranes were allowed to dry and the bands below to the TTR monomer, corresponding to TTR fragments (band 1 and band 2) were excised for N-terminal sequencing analysis (Edman degradation method) using an ABI Procise Protein Sequencer, an ABI Microgradient Pump System, and an ABI Programmable Absorbance Detector (Applied Biosystems Inc., Waltham, MA, USA).</p></section><section id="sec4dot5-ijms-22-09488"><h3 class="pmc_sec_title">4.5. Mass Spectrometry Analysis for the Identification of TTR Fragments</h3>
<p>Gel bands excised from SDS-PAGE were washed twice with 50% acetonitrile (ACN) in 50 mM triethylammonium bicarbonate (TEAB) with shaking at 1500 rpm for 5 min and further treated with ACN twice. Then, proteins were reduced with 25 mM dithiothreitol (DTT) for 20 min at 56 °C and alkylated with 55 mM iodoacetamide (IAA) for 20 min at room temperature in the dark, followed by the same wash procedure. Proteins were then digested with trypsin (240 ng) in 50 mM TEAB/0.01% surfactant (ProteaseMAX, Promega, Madison, WI, USA) for 60 min at 50 °C. Peptide gel extraction was performed with 2.5% trifluoroacetic acid (TFA) followed by 50% ACN, 0.1% TFA. Samples were dried using Speedvac, resuspended in 10mL 0.1% TFA and cleaned by C18 reverse phase chromatography according to manufacturer’s instructions (ZipTip, Sigma-Merck, Darmstadt, Germany).</p>
<p>Sample protein identification and quantification were performed by nano-liquid chromatography mass spectrometry (nano LC-MS/MS), as previously described [<a href="#B50-ijms-22-09488" class="usa-link" aria-describedby="B50-ijms-22-09488">50</a>] with a 90 min chromatographic separation run. This equipment was composed of an Ultimate 3000 liquid chromatography system coupled to a Q-Exactive Hybrid Quadrupole-Orbitrap mass spectrometer (Thermo Scientific, Bremen, Germany). A total of 500 nanograms of each TTR peptide were loaded onto a trapping cartridge (Acclaim PepMap C18 100 Å, 5 mm × 300 µm i.d., 160454, Thermo Scientific, Bremen, Germany) in a mobile phase of 2% ACN, 0.1% FA at 10 µL/min. After 3 min loading, the trap column was switched in-line to a 50 cm × 75 μm inner diameter EASY-Spray column (ES803, PepMap RSLC, C18, 2 μm, Thermo Scientific, Bremen, Germany) at 250 nL/min. The LC separation was achieved by mixing A: 0.1% FA and B: 80% ACN, 0.1% FA with the following gradient: 2 min (2.5% B to 10% B), 50 min (10% B to 35% B), 8 min (35% B to 99% B), and 10 min (hold 99% B). Subsequently, the column was equilibrated with 2.5% B for 17 min. The specific MS parameters were: MS maximum injection time, 100 ms; dd settings: minimum AGC target 7 × 103, intensity threshold 6.4 × 104, and dynamic exclusion 20 s. Data acquisition was controlled by Tune 2.11 software (Thermo Scientific, Bremen, Germany). The UniProt database 2020_05 for the Homo sapiens proteome (75069 entries) together with a customized TTR amino acid sequence were considered for protein identification. Protein identification was performed with the Proteome Discoverer software v2.5 (Thermo Scientific, Bremen, Germany). Proteins were quantified by Label-Free Quantification—LFQ, with precursor quantification based on intensity.</p></section><section id="sec4dot6-ijms-22-09488"><h3 class="pmc_sec_title">4.6. Aggregation Studies: Dynamic Light Scattering and Thioflavin T Assay</h3>
<p>DLS measurements were performed at 25 °C using Malvern Zetasizer Nano ZS apparatus (Malvern, Worcestershire, UK). Each sample was measured 3 times, and the values exhibited in the curves were the average distributions from those triplicates. Thioflavin T (ThT) assay was performed in PBS (pH = 7.4) using a 96-well black bottom plate. TTR (12.5 μg) and ThT (30 μM) (Sigma-Merck, Darmstadt, Germany) per well were mixed and, the fluorescence was measured at Exc./Em = 450 nm/482 nm using SynergyMx apparatus (BioTeK, Winooski, VT, USA).</p></section><section id="sec4dot7-ijms-22-09488"><h3 class="pmc_sec_title">4.7. Mice</h3>
<p>Mice were kept in a controlled temperature room and maintained under a 12 h light/dark period. Transgenic mice carrying human TTR V30M (HM30) were bred as described before [<a href="#B51-ijms-22-09488" class="usa-link" aria-describedby="B51-ijms-22-09488">51</a>]. Both younger (12–13 months; <em>n</em> = 12) and older (16–21 months; <em>n</em> = 7) HM30 mice were subcutaneously (s.c) injected once a week with 5 mg ASO/kg body weight following previous protocols [<a href="#B48-ijms-22-09488" class="usa-link" aria-describedby="B48-ijms-22-09488">48</a>]. Animals were euthanized at week 6 of treatment. Plasma and tissue sections were collected and frozen at −80 °C or fixed in formalin for further analysis.</p></section><section id="sec4dot8-ijms-22-09488"><h3 class="pmc_sec_title">4.8. Determination of SerpinA1 and TTR Protein Levels in Mice Heart</h3>
<p>Mouse hearts were homogenized using RIPA lysis and extraction buffer according to the manufacturer’s instructions (Santa Cruz Biotechnology, Dallas, TX, USA). Briefly, mouse hearts were homogenized in RIPA buffer using a laboratory homogenizer to disrupt the tissue. Protein homogenates were further frizzed at −80 °C to promote cell lysis, further centrifuged at 21,500× <em>g</em> for 15 min at 4 °C and, the supernatant containing protein was harvested. Protein was quantified in the heart lysates using Bradford protein assay (BioRad, Hercules, CA, USA), and 50 μg of total protein was loaded into a 10% and 15% polyacrylamide SDS-PAGE to evaluate SerpinA1 and TTR expression, respectively. Gels were then transferred onto nitrocellulose membrane using a wet system and, membranes were incubated overnight with rat monoclonal anti-mouse SerpinA1 antibody (1:1000; R&amp;D systems, Minneapolis, MN, USA), rabbit polyclonal anti-human TTR antibody (1:1000, DAKO) or mouse anti-transthyretin mutant (Y78F), clone AD7 (1:100, Sigma-Merck, Darmstadt, Germany). GAPDH was used as a protein loading control, and recombinant rabbit anti-GAPDH antibody was used for immunoblotting (1:100000, Abcam, Cambridge, UK). ECL chemiluminescence reagent (Bio-Rad, Hercules, CA, USA) was used as a detection method using Chemidoc apparatus (Bio-Rad, Hercules, CA, USA). Protein bands were quantified by densitometry using ImageJ (U. S. National Institutes of Health, Bethesda, MD, USA), and results of protein expression were normalized to GAPDH expression.</p></section><section id="sec4dot9-ijms-22-09488"><h3 class="pmc_sec_title">4.9. Immunohistochemical Analysis of Tissue TTR Deposition</h3>
<p>Paraffin-embedded sections of both duodenal and cardiac tissue were deparaffinized in xylene and rehydrated in descent alcohol series. Antigen retrieval was performed at 95 °C for 15 min using citrate buffer (pH = 6) and, then, endogenous peroxidase activity was quenched in 3% hydrogen peroxide in methanol. Sections were blocked using 10% fetal bovine serum, 1% bovine serum albumin, and 0.5% Triton X-100 in PBS. TTR immunostaining was performed using primary rabbit polyclonal anti-human TTR antibody (1:600, DAKO, Hovedstaden, Denmark) and secondary anti-rabbit antibody (1:200) (Vector, Burlingame, CA, USA). For SerpinA1 staining, primary rat anti-mouse antibody (1:100; R&amp;D systems, Minneapolis, MN, USA) and secondary anti-rat antibody (1:200) (Vector, Burlingame, CA, USA) were used. Tissue slides were developed using 3,3′-diaminobenzidine (DAB) (DAKO, Hovedstaden, Denmark), counterstained with hematoxylin and mounted in Entellan<sup>®</sup> (Sigma-Merck, Darmstadt, Germany). Images were captured at 10x magnification using Olympus BX50 microscope (Shinjuku, Tokyo, Japan) and analyzed using Image Pro Plus software (Rockville, MD, USA). Results represent the occupied area in pixels corresponding to the substrate reaction color that was further normalized relative to the total image area.</p></section><section id="sec4dot10-ijms-22-09488"><h3 class="pmc_sec_title">4.10. Protease Activity and Plasmin Activity Fluorescence Measurements</h3>
<p>Plasma samples and heart homogenates from HM30 mice were directly used without any dilution. However, protein from heart homogenates was extracted by using RIPA lysis and extraction buffer without supplementation with protease inhibitors. Protease activity assay and plasmin activity assay kits were used according to the manufacturer’s instructions. Briefly, mice samples were incubated with FITC-casein substrate in protease activity assay, whereas in the plasmin activity assay, samples were incubated with a synthetic plasmin AMC-substrate. The fluorescence was measured at Ex/Em = 485/530 nm and Ex/Em = 360/450 nm in protease activity assay kit (Abcam, Cambridge, UK) and plasmin activity assay kit (Abcam, Cambridge, UK), respectively, using SynergyMx apparatus (BioTek, Winooski, VT, USA). Both protease and plasmin activities were calculated according to the manufacturer’s instructions.</p></section><section id="sec4dot11-ijms-22-09488"><h3 class="pmc_sec_title">4.11. Statistical Analysis</h3>
<p>Statistical analysis was performed by one-way ANOVA (Tukey’s multiple comparisons as post-test) and unpaired t-test using GraphPad Prism 5 software (San Diego, CA, USA). Statistical significance was considered when <em>p</em>-value ≤ 0.05. Results were expressed as mean + standard error of the mean (SEM).</p></section></section><section id="ack1" class="ack"><h2 class="pmc_sec_title">Acknowledgments</h2>
<p>The authors acknowledge technical assistance of Paula Chicau from N-terminal sequencing facility of ITQB Nova, Lisbon, Portugal for N-terminal sequencing experiments and data analysis. The authors also acknowledge to Hugo Osório from Proteomics Unit of i3S (Instituto de Investigação e Inovação em Saúde) for mass spectrometry experiments and analysis.</p></section><section id="app1-ijms-22-09488" class="app"><h2 class="pmc_sec_title">Supplementary Materials</h2>
<p>Supplementary Materials can be found at <a href="http://www.mdpi.com/article/10.3390/ijms22179488/s1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">www.mdpi.com/article/10.3390/ijms22179488/s1</a>.</p>
<section class="sm xbox font-sm" id="ijms-22-09488-s001"><div class="media p"><div class="caption">
<a href="/articles/instance/8430710/bin/ijms-22-09488-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (1.2MB, zip) </sup>
</div></div></section></section><section id="notes1"><h2 class="pmc_sec_title">Author Contributions</h2>
<p>Conceived and designed the experiments: F.B., C.N., H.H.J.S., A.Z., M.J.S., M.R.A. Performed the experiments: F.B., P.G. Analyzed the data: F.B., P.G., A.Z., M.J.S., M.R.A. Contributed reagents/materials/analysis tools: S.G., B.P.M., M.J.S., M.R.A. Writing the paper: F.B., A.Z., M.J.S., M.R.A. All authors have read and agreed to the published version of the manuscript.</p></section><section id="notes2"><h2 class="pmc_sec_title">Funding</h2>
<p>This research was funded by COMPETE 2020 of PT2020 through the European Regional Development Fund (ERDF), “NETDIAMOND—New Targets in DIAstolic heart failure: from coMOrbidities to persoNalizeD medicine” project financed by the European Structural and Investment Funds (ESIF), through the Programa Operacional Regional (POCI-01-0145-FEDER-016385) and HEALTH-UNORTE: Setting-up biobanks and regenerative medicine strategies to boost research in cardiovascular, musculoskeletal, neurological, oncological, immunological, and infectious diseases, NORTE-01-0145-FEDER-000039. FB was supported by FCT—Fundação para a Ciência e Tecnologia/MEC—Ministério da Educação e Ciência with a PhD fellowship (SFRH/BD/123674/2016).</p></section><section id="notes3"><h2 class="pmc_sec_title">Institutional Review Board Statement</h2>
<p>All animal experiments were approved by the Portuguese General Veterinarian Board (authorization number 014982 from DGV-Portugal) and animals were kept and used strictly in accordance with National rules and the European Communities Council Directive (86/609/EEC), for the care and handling of laboratory animals.</p></section><section id="notes4"><h2 class="pmc_sec_title">Informed Consent Statement</h2>
<p>Not applicable.</p></section><section id="notes5"><h2 class="pmc_sec_title">Data Availability Statement</h2>
<p>Data are contained within the article or <a href="#app1-ijms-22-09488" class="usa-link">Supplementary Materials</a>.</p></section><section id="notes6"><h2 class="pmc_sec_title">Conflicts of Interest</h2>
<p>The authors declare no conflict of interest.</p></section><section id="fn-group1" class="fn-group"><h2 class="pmc_sec_title">Footnotes</h2>
<div class="fn-group p font-secondary-light font-sm"><div class="fn p" id="fn2"><p><strong>Publisher’s Note:</strong> MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.</p></div></div></section><section id="ref-list1" class="ref-list"><h2 class="pmc_sec_title">References</h2>
<section id="ref-list1_sec2"><ul class="ref-list font-sm" style="list-style-type:none">
<li id="B1-ijms-22-09488">
<span class="label">1.</span><cite>Koike H., Katsuno M. Transthyretin Amyloidosis: Update on the Clinical Spectrum, Pathogenesis, and Disease-Modifying Therapies. Neurol. Ther. 2020;9:317–333. doi: 10.1007/s40120-020-00210-7.</cite> [<a href="https://doi.org/10.1007/s40120-020-00210-7" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7500251/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32948978/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neurol.%20Ther.&amp;title=Transthyretin%20Amyloidosis:%20Update%20on%20the%20Clinical%20Spectrum,%20Pathogenesis,%20and%20Disease-Modifying%20Therapies&amp;author=H.%20Koike&amp;author=M.%20Katsuno&amp;volume=9&amp;publication_year=2020&amp;pages=317-333&amp;pmid=32948978&amp;doi=10.1007/s40120-020-00210-7&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B2-ijms-22-09488">
<span class="label">2.</span><cite>Nativi-Nicolau J.N., Karam C., Khella S., Maurer M.S. Screening for ATTR amyloidosis in the clinic: Overlapping disorders, misdiagnosis, and multiorgan awareness. Heart Fail. Rev. 2021:1–9. doi: 10.1007/s10741-021-10080-2.</cite> [<a href="https://doi.org/10.1007/s10741-021-10080-2" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC9033715/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33609196/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Heart%20Fail.%20Rev.&amp;title=Screening%20for%20ATTR%20amyloidosis%20in%20the%20clinic:%20Overlapping%20disorders,%20misdiagnosis,%20and%20multiorgan%20awareness&amp;author=J.N.%20Nativi-Nicolau&amp;author=C.%20Karam&amp;author=S.%20Khella&amp;author=M.S.%20Maurer&amp;publication_year=2021&amp;pages=1-9&amp;pmid=33609196&amp;doi=10.1007/s10741-021-10080-2&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B3-ijms-22-09488">
<span class="label">3.</span><cite>Benson M.D., Buxbaum J.N., Eisenberg D.S., Merlini G., Saraiva M.J.M., Sekijima Y., Sipe J.D., Westermark P. Amyloid nomenclature 2018: Recommendations by the International Society of Amyloidosis (ISA) nomenclature committee. Amyloid Int. J. Exp. Clin. Investig. Off. J. Int. Soc. Amyloidosis. 2018;25:215–219. doi: 10.1080/13506129.2018.1549825.</cite> [<a href="https://doi.org/10.1080/13506129.2018.1549825" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30614283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid%20Int.%20J.%20Exp.%20Clin.%20Investig.%20Off.%20J.%20Int.%20Soc.%20Amyloidosis&amp;title=Amyloid%20nomenclature%202018:%20Recommendations%20by%20the%20International%20Society%20of%20Amyloidosis%20(ISA)%20nomenclature%20committee&amp;author=M.D.%20Benson&amp;author=J.N.%20Buxbaum&amp;author=D.S.%20Eisenberg&amp;author=G.%20Merlini&amp;author=M.J.M.%20Saraiva&amp;volume=25&amp;publication_year=2018&amp;pages=215-219&amp;pmid=30614283&amp;doi=10.1080/13506129.2018.1549825&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B4-ijms-22-09488">
<span class="label">4.</span><cite>Saraiva M.J. Transthyretin mutations in health and disease. Hum. Mutat. 1995;5:191–196. doi: 10.1002/humu.1380050302.</cite> [<a href="https://doi.org/10.1002/humu.1380050302" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/7599630/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Mutat.&amp;title=Transthyretin%20mutations%20in%20health%20and%20disease&amp;author=M.J.%20Saraiva&amp;volume=5&amp;publication_year=1995&amp;pages=191-196&amp;pmid=7599630&amp;doi=10.1002/humu.1380050302&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B5-ijms-22-09488">
<span class="label">5.</span><cite>Hurshman Babbes A.R., Powers E.T., Kelly J.W. Quantification of the thermodynamically linked quaternary and tertiary structural stabilities of transthyretin and its disease-associated variants: The relationship between stability and amyloidosis. Biochemistry. 2008;47:6969–6984. doi: 10.1021/bi800636q.</cite> [<a href="https://doi.org/10.1021/bi800636q" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC2667099/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18537267/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Quantification%20of%20the%20thermodynamically%20linked%20quaternary%20and%20tertiary%20structural%20stabilities%20of%20transthyretin%20and%20its%20disease-associated%20variants:%20The%20relationship%20between%20stability%20and%20amyloidosis&amp;author=A.R.%20Hurshman%20Babbes&amp;author=E.T.%20Powers&amp;author=J.W.%20Kelly&amp;volume=47&amp;publication_year=2008&amp;pages=6969-6984&amp;pmid=18537267&amp;doi=10.1021/bi800636q&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B6-ijms-22-09488">
<span class="label">6.</span><cite>Sekijima Y., Wiseman R.L., Matteson J., Hammarstrom P., Miller S.R., Sawkar A.R., Balch W.E., Kelly J.W. The biological and chemical basis for tissue-selective amyloid disease. Cell. 2005;121:73–85. doi: 10.1016/j.cell.2005.01.018.</cite> [<a href="https://doi.org/10.1016/j.cell.2005.01.018" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15820680/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Cell&amp;title=The%20biological%20and%20chemical%20basis%20for%20tissue-selective%20amyloid%20disease&amp;author=Y.%20Sekijima&amp;author=R.L.%20Wiseman&amp;author=J.%20Matteson&amp;author=P.%20Hammarstrom&amp;author=S.R.%20Miller&amp;volume=121&amp;publication_year=2005&amp;pages=73-85&amp;pmid=15820680&amp;doi=10.1016/j.cell.2005.01.018&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B7-ijms-22-09488">
<span class="label">7.</span><cite>Westermark P., Bergstrom J., Solomon A., Murphy C., Sletten K. Transthyretin-derived senile systemic amyloidosis: Clinicopathologic and structural considerations. Amyloid Int. J. Exp. Clin. Investig. Off. J. Int. Soc. Amyloidosis. 2003;10(Suppl. 1):48–54. doi: 10.1080/13506129.2003.12088568.</cite> [<a href="https://doi.org/10.1080/13506129.2003.12088568" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/14640042/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid%20Int.%20J.%20Exp.%20Clin.%20Investig.%20Off.%20J.%20Int.%20Soc.%20Amyloidosis&amp;title=Transthyretin-derived%20senile%20systemic%20amyloidosis:%20Clinicopathologic%20and%20structural%20considerations&amp;author=P.%20Westermark&amp;author=J.%20Bergstrom&amp;author=A.%20Solomon&amp;author=C.%20Murphy&amp;author=K.%20Sletten&amp;volume=10&amp;issue=Suppl.%201&amp;publication_year=2003&amp;pages=48-54&amp;pmid=14640042&amp;doi=10.1080/13506129.2003.12088568&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B8-ijms-22-09488">
<span class="label">8.</span><cite>Sipe J.D., Benson M.D., Buxbaum J.N., Ikeda S.I., Merlini G., Saraiva M.J., Westermark P. Amyloid fibril proteins and amyloidosis: Chemical identification and clinical classification International Society of Amyloidosis 2016 Nomenclature Guidelines. Amyloid Int. J. Exp. Clin. Investig. Off. J. Int. Soc. Amyloidosis. 2016;23:209–213. doi: 10.1080/13506129.2016.1257986.</cite> [<a href="https://doi.org/10.1080/13506129.2016.1257986" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/27884064/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid%20Int.%20J.%20Exp.%20Clin.%20Investig.%20Off.%20J.%20Int.%20Soc.%20Amyloidosis&amp;title=Amyloid%20fibril%20proteins%20and%20amyloidosis:%20Chemical%20identification%20and%20clinical%20classification%20International%20Society%20of%20Amyloidosis%202016%20Nomenclature%20Guidelines&amp;author=J.D.%20Sipe&amp;author=M.D.%20Benson&amp;author=J.N.%20Buxbaum&amp;author=S.I.%20Ikeda&amp;author=G.%20Merlini&amp;volume=23&amp;publication_year=2016&amp;pages=209-213&amp;pmid=27884064&amp;doi=10.1080/13506129.2016.1257986&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B9-ijms-22-09488">
<span class="label">9.</span><cite>McCutchen S.L., Colon W., Kelly J.W. Transthyretin mutation Leu-55-Pro significantly alters tetramer stability and increases amyloidogenicity. Biochemistry. 1993;32:12119–12127. doi: 10.1021/bi00096a024.</cite> [<a href="https://doi.org/10.1021/bi00096a024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/8218290/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Transthyretin%20mutation%20Leu-55-Pro%20significantly%20alters%20tetramer%20stability%20and%20increases%20amyloidogenicity&amp;author=S.L.%20McCutchen&amp;author=W.%20Colon&amp;author=J.W.%20Kelly&amp;volume=32&amp;publication_year=1993&amp;pages=12119-12127&amp;pmid=8218290&amp;doi=10.1021/bi00096a024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B10-ijms-22-09488">
<span class="label">10.</span><cite>Quintas A., Vaz D.C., Cardoso I., Saraiva M.J., Brito R.M. Tetramer dissociation and monomer partial unfolding precedes protofibril formation in amyloidogenic transthyretin variants. J. Biol. Chem. 2001;276:27207–27213. doi: 10.1074/jbc.M101024200.</cite> [<a href="https://doi.org/10.1074/jbc.M101024200" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11306576/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Tetramer%20dissociation%20and%20monomer%20partial%20unfolding%20precedes%20protofibril%20formation%20in%20amyloidogenic%20transthyretin%20variants&amp;author=A.%20Quintas&amp;author=D.C.%20Vaz&amp;author=I.%20Cardoso&amp;author=M.J.%20Saraiva&amp;author=R.M.%20Brito&amp;volume=276&amp;publication_year=2001&amp;pages=27207-27213&amp;pmid=11306576&amp;doi=10.1074/jbc.M101024200&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B11-ijms-22-09488">
<span class="label">11.</span><cite>Si J.B., Kim B., Kim J.H. Transthyretin Misfolding, A Fatal Structural Pathogenesis Mechanism. Int. J. Mol. Sci. 2021;22:4429.  doi: 10.3390/ijms22094429.</cite> [<a href="https://doi.org/10.3390/ijms22094429" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC8122960/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33922648/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Int.%20J.%20Mol.%20Sci.&amp;title=Transthyretin%20Misfolding,%20A%20Fatal%20Structural%20Pathogenesis%20Mechanism&amp;author=J.B.%20Si&amp;author=B.%20Kim&amp;author=J.H.%20Kim&amp;volume=22&amp;publication_year=2021&amp;pages=4429&amp;pmid=33922648&amp;doi=10.3390/ijms22094429&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B12-ijms-22-09488">
<span class="label">12.</span><cite>Cardoso I., Goldsbury C.S., Muller S.A., Olivieri V., Wirtz S., Damas A.M., Aebi U., Saraiva M.J. Transthyretin fibrillogenesis entails the assembly of monomers: A molecular model for in vitro assembled transthyretin amyloid-like fibrils. J. Mol. Biol. 2002;317:683–695. doi: 10.1006/jmbi.2002.5441.</cite> [<a href="https://doi.org/10.1006/jmbi.2002.5441" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11955017/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Biol.&amp;title=Transthyretin%20fibrillogenesis%20entails%20the%20assembly%20of%20monomers:%20A%20molecular%20model%20for%20in%20vitro%20assembled%20transthyretin%20amyloid-like%20fibrils&amp;author=I.%20Cardoso&amp;author=C.S.%20Goldsbury&amp;author=S.A.%20Muller&amp;author=V.%20Olivieri&amp;author=S.%20Wirtz&amp;volume=317&amp;publication_year=2002&amp;pages=683-695&amp;pmid=11955017&amp;doi=10.1006/jmbi.2002.5441&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B13-ijms-22-09488">
<span class="label">13.</span><cite>Bergstrom J., Gustavsson A., Hellman U., Sletten K., Murphy C.L., Weiss D.T., Solomon A., Olofsson B.O., Westermark P. Amyloid deposits in transthyretin-derived amyloidosis: Cleaved transthyretin is associated with distinct amyloid morphology. J. Pathol. 2005;206:224–232. doi: 10.1002/path.1759.</cite> [<a href="https://doi.org/10.1002/path.1759" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15810051/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pathol.&amp;title=Amyloid%20deposits%20in%20transthyretin-derived%20amyloidosis:%20Cleaved%20transthyretin%20is%20associated%20with%20distinct%20amyloid%20morphology&amp;author=J.%20Bergstrom&amp;author=A.%20Gustavsson&amp;author=U.%20Hellman&amp;author=K.%20Sletten&amp;author=C.L.%20Murphy&amp;volume=206&amp;publication_year=2005&amp;pages=224-232&amp;pmid=15810051&amp;doi=10.1002/path.1759&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B14-ijms-22-09488">
<span class="label">14.</span><cite>Ihse E., Ybo A., Suhr O., Lindqvist P., Backman C., Westermark P. Amyloid fibril composition is related to the phenotype of hereditary transthyretin V30M amyloidosis. J. Pathol. 2008;216:253–261. doi: 10.1002/path.2411.</cite> [<a href="https://doi.org/10.1002/path.2411" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/18729067/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Pathol.&amp;title=Amyloid%20fibril%20composition%20is%20related%20to%20the%20phenotype%20of%20hereditary%20transthyretin%20V30M%20amyloidosis&amp;author=E.%20Ihse&amp;author=A.%20Ybo&amp;author=O.%20Suhr&amp;author=P.%20Lindqvist&amp;author=C.%20Backman&amp;volume=216&amp;publication_year=2008&amp;pages=253-261&amp;pmid=18729067&amp;doi=10.1002/path.2411&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B15-ijms-22-09488">
<span class="label">15.</span><cite>Ihse E., Rapezzi C., Merlini G., Benson M.D., Ando Y., Suhr O.B., Ikeda S., Lavatelli F., Obici L., Quarta C.C., et al.  Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. Amyloid Int. J. Exp. Clin. Investig. Off. J. Int. Soc. Amyloidosis. 2013;20:142–150. doi: 10.3109/13506129.2013.797890.</cite> [<a href="https://doi.org/10.3109/13506129.2013.797890" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23713495/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid%20Int.%20J.%20Exp.%20Clin.%20Investig.%20Off.%20J.%20Int.%20Soc.%20Amyloidosis&amp;title=Amyloid%20fibrils%20containing%20fragmented%20ATTR%20may%20be%20the%20standard%20fibril%20composition%20in%20ATTR%20amyloidosis&amp;author=E.%20Ihse&amp;author=C.%20Rapezzi&amp;author=G.%20Merlini&amp;author=M.D.%20Benson&amp;author=Y.%20Ando&amp;volume=20&amp;publication_year=2013&amp;pages=142-150&amp;pmid=23713495&amp;doi=10.3109/13506129.2013.797890&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B16-ijms-22-09488">
<span class="label">16.</span><cite>Ihse E., Suhr O.B., Hellman U., Westermark P. Variation in amount of wild-type transthyretin in different fibril and tissue types in ATTR amyloidosis. J. Mol. Med. 2011;89:171–180. doi: 10.1007/s00109-010-0695-1.</cite> [<a href="https://doi.org/10.1007/s00109-010-0695-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3022153/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/21107516/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Med.&amp;title=Variation%20in%20amount%20of%20wild-type%20transthyretin%20in%20different%20fibril%20and%20tissue%20types%20in%20ATTR%20amyloidosis&amp;author=E.%20Ihse&amp;author=O.B.%20Suhr&amp;author=U.%20Hellman&amp;author=P.%20Westermark&amp;volume=89&amp;publication_year=2011&amp;pages=171-180&amp;pmid=21107516&amp;doi=10.1007/s00109-010-0695-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B17-ijms-22-09488">
<span class="label">17.</span><cite>Gustafsson S., Ihse E., Henein M.Y., Westermark P., Lindqvist P., Suhr O.B. Amyloid fibril composition as a predictor of development of cardiomyopathy after liver transplantation for hereditary transthyretin amyloidosis. Transplantation. 2012;93:1017–1023. doi: 10.1097/TP.0b013e31824b3749.</cite> [<a href="https://doi.org/10.1097/TP.0b013e31824b3749" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/22395298/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Transplantation&amp;title=Amyloid%20fibril%20composition%20as%20a%20predictor%20of%20development%20of%20cardiomyopathy%20after%20liver%20transplantation%20for%20hereditary%20transthyretin%20amyloidosis&amp;author=S.%20Gustafsson&amp;author=E.%20Ihse&amp;author=M.Y.%20Henein&amp;author=P.%20Westermark&amp;author=P.%20Lindqvist&amp;volume=93&amp;publication_year=2012&amp;pages=1017-1023&amp;pmid=22395298&amp;doi=10.1097/TP.0b013e31824b3749&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B18-ijms-22-09488">
<span class="label">18.</span><cite>Sant’Anna R., Braga C., Varejao N., Pimenta K.M., Grana-Montes R., Alves A., Cortines J., Cordeiro Y., Ventura S., Foguel D. The importance of a gatekeeper residue on the aggregation of transthyretin: Implications for transthyretin-related amyloidoses. J. Biol. Chem. 2014;289:28324–28337. doi: 10.1074/jbc.M114.563981.</cite> [<a href="https://doi.org/10.1074/jbc.M114.563981" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4192486/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25086037/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=The%20importance%20of%20a%20gatekeeper%20residue%20on%20the%20aggregation%20of%20transthyretin:%20Implications%20for%20transthyretin-related%20amyloidoses&amp;author=R.%20Sant%E2%80%99Anna&amp;author=C.%20Braga&amp;author=N.%20Varejao&amp;author=K.M.%20Pimenta&amp;author=R.%20Grana-Montes&amp;volume=289&amp;publication_year=2014&amp;pages=28324-28337&amp;pmid=25086037&amp;doi=10.1074/jbc.M114.563981&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B19-ijms-22-09488">
<span class="label">19.</span><cite>Mangione P.P., Porcari R., Gillmore J.D., Pucci P., Monti M., Porcari M., Giorgetti S., Marchese L., Raimondi S., Serpell L.C., et al.  Proteolytic cleavage of Ser52Pro variant transthyretin triggers its amyloid fibrillogenesis. Proc. Natl. Acad. Sci. USA. 2014;111:1539–1544. doi: 10.1073/pnas.1317488111.</cite> [<a href="https://doi.org/10.1073/pnas.1317488111" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3910611/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24474780/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=Proteolytic%20cleavage%20of%20Ser52Pro%20variant%20transthyretin%20triggers%20its%20amyloid%20fibrillogenesis&amp;author=P.P.%20Mangione&amp;author=R.%20Porcari&amp;author=J.D.%20Gillmore&amp;author=P.%20Pucci&amp;author=M.%20Monti&amp;volume=111&amp;publication_year=2014&amp;pages=1539-1544&amp;pmid=24474780&amp;doi=10.1073/pnas.1317488111&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B20-ijms-22-09488">
<span class="label">20.</span><cite>Marcoux J., Mangione P.P., Porcari R., Degiacomi M.T., Verona G., Taylor G.W., Giorgetti S., Raimondi S., Sanglier-Cianferani S., Benesch J.L., et al.  A novel mechano-enzymatic cleavage mechanism underlies transthyretin amyloidogenesis. EMBO Mol. Med. 2015;7:1337–1349. doi: 10.15252/emmm.201505357.</cite> [<a href="https://doi.org/10.15252/emmm.201505357" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4604687/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26286619/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=EMBO%20Mol.%20Med.&amp;title=A%20novel%20mechano-enzymatic%20cleavage%20mechanism%20underlies%20transthyretin%20amyloidogenesis&amp;author=J.%20Marcoux&amp;author=P.P.%20Mangione&amp;author=R.%20Porcari&amp;author=M.T.%20Degiacomi&amp;author=G.%20Verona&amp;volume=7&amp;publication_year=2015&amp;pages=1337-1349&amp;pmid=26286619&amp;doi=10.15252/emmm.201505357&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B21-ijms-22-09488">
<span class="label">21.</span><cite>Klimtchuk E.S., Prokaeva T., Frame N.M., Abdullahi H.A., Spencer B., Dasari S., Cui H., Berk J.L., Kurtin P.J., Connors L.H., et al.  Unusual duplication mutation in a surface loop of human transthyretin leads to an aggressive drug-resistant amyloid disease. Proc. Natl. Acad. Sci. USA. 2018;115:E6428–E6436. doi: 10.1073/pnas.1802977115.</cite> [<a href="https://doi.org/10.1073/pnas.1802977115" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6048550/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29941560/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Proc.%20Natl.%20Acad.%20Sci.%20USA&amp;title=Unusual%20duplication%20mutation%20in%20a%20surface%20loop%20of%20human%20transthyretin%20leads%20to%20an%20aggressive%20drug-resistant%20amyloid%20disease&amp;author=E.S.%20Klimtchuk&amp;author=T.%20Prokaeva&amp;author=N.M.%20Frame&amp;author=H.A.%20Abdullahi&amp;author=B.%20Spencer&amp;volume=115&amp;publication_year=2018&amp;pages=E6428-E6436&amp;pmid=29941560&amp;doi=10.1073/pnas.1802977115&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B22-ijms-22-09488">
<span class="label">22.</span><cite>Mangione P.P., Verona G., Corazza A., Marcoux J., Canetti D., Giorgetti S., Raimondi S., Stoppini M., Esposito M., Relini A., et al.  Plasminogen activation triggers transthyretin amyloidogenesis in vitro. J. Biol. Chem. 2018;293:14192–14199. doi: 10.1074/jbc.RA118.003990.</cite> [<a href="https://doi.org/10.1074/jbc.RA118.003990" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6139548/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30018138/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Plasminogen%20activation%20triggers%20transthyretin%20amyloidogenesis%20in%20vitro&amp;author=P.P.%20Mangione&amp;author=G.%20Verona&amp;author=A.%20Corazza&amp;author=J.%20Marcoux&amp;author=D.%20Canetti&amp;volume=293&amp;publication_year=2018&amp;pages=14192-14199&amp;pmid=30018138&amp;doi=10.1074/jbc.RA118.003990&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B23-ijms-22-09488">
<span class="label">23.</span><cite>Tucker H.M., Kihiko-Ehmann M., Wright S., Rydel R.E., Estus S. Tissue plasminogen activator requires plasminogen to modulate amyloid-beta neurotoxicity and deposition. J. Neurochem. 2000;75:2172–2177. doi: 10.1046/j.1471-4159.2000.0752172.x.</cite> [<a href="https://doi.org/10.1046/j.1471-4159.2000.0752172.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/11032907/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurochem.&amp;title=Tissue%20plasminogen%20activator%20requires%20plasminogen%20to%20modulate%20amyloid-beta%20neurotoxicity%20and%20deposition&amp;author=H.M.%20Tucker&amp;author=M.%20Kihiko-Ehmann&amp;author=S.%20Wright&amp;author=R.E.%20Rydel&amp;author=S.%20Estus&amp;volume=75&amp;publication_year=2000&amp;pages=2172-2177&amp;pmid=11032907&amp;doi=10.1046/j.1471-4159.2000.0752172.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B24-ijms-22-09488">
<span class="label">24.</span><cite>Mumford A.D., O’Donnell J., Gillmore J.D., Manning R.A., Hawkins P.N., Laffan M. Bleeding symptoms and coagulation abnormalities in 337 patients with AL-amyloidosis. Br. J. Haematol. 2000;110:454–460. doi: 10.1046/j.1365-2141.2000.02183.x.</cite> [<a href="https://doi.org/10.1046/j.1365-2141.2000.02183.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10971408/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Br.%20J.%20Haematol.&amp;title=Bleeding%20symptoms%20and%20coagulation%20abnormalities%20in%20337%20patients%20with%20AL-amyloidosis&amp;author=A.D.%20Mumford&amp;author=J.%20O%E2%80%99Donnell&amp;author=J.D.%20Gillmore&amp;author=R.A.%20Manning&amp;author=P.N.%20Hawkins&amp;volume=110&amp;publication_year=2000&amp;pages=454-460&amp;pmid=10971408&amp;doi=10.1046/j.1365-2141.2000.02183.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B25-ijms-22-09488">
<span class="label">25.</span><cite>Bouma B., Maas C., Hazenberg B.P., Lokhorst H.M., Gebbink M.F. Increased plasmin-alpha2-antiplasmin levels indicate activation of the fibrinolytic system in systemic amyloidoses. J. Thromb. Haemost. JTH. 2007;5:1139–1142. doi: 10.1111/j.1538-7836.2007.02457.x.</cite> [<a href="https://doi.org/10.1111/j.1538-7836.2007.02457.x" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17371485/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Thromb.%20Haemost.%20JTH&amp;title=Increased%20plasmin-alpha2-antiplasmin%20levels%20indicate%20activation%20of%20the%20fibrinolytic%20system%20in%20systemic%20amyloidoses&amp;author=B.%20Bouma&amp;author=C.%20Maas&amp;author=B.P.%20Hazenberg&amp;author=H.M.%20Lokhorst&amp;author=M.F.%20Gebbink&amp;volume=5&amp;publication_year=2007&amp;pages=1139-1142&amp;pmid=17371485&amp;doi=10.1111/j.1538-7836.2007.02457.x&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B26-ijms-22-09488">
<span class="label">26.</span><cite>Uchiba M., Imamura T., Hata H., Tatetsu H., Yonemura Y., Ueda M., Wada Y., Mitsuya H., Ando Y. Excessive fibrinolysis in AL-amyloidosis is induced by urokinae-type plasminogen activator from bone marrow plasma cells. Amyloid Int. J. Exp. Clin. Investig. Off. J. Int. Soc. Amyloidosis. 2009;16:89–93. doi: 10.1080/13506120902879269.</cite> [<a href="https://doi.org/10.1080/13506120902879269" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/20536401/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid%20Int.%20J.%20Exp.%20Clin.%20Investig.%20Off.%20J.%20Int.%20Soc.%20Amyloidosis&amp;title=Excessive%20fibrinolysis%20in%20AL-amyloidosis%20is%20induced%20by%20urokinae-type%20plasminogen%20activator%20from%20bone%20marrow%20plasma%20cells&amp;author=M.%20Uchiba&amp;author=T.%20Imamura&amp;author=H.%20Hata&amp;author=H.%20Tatetsu&amp;author=Y.%20Yonemura&amp;volume=16&amp;publication_year=2009&amp;pages=89-93&amp;pmid=20536401&amp;doi=10.1080/13506120902879269&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B27-ijms-22-09488">
<span class="label">27.</span><cite>Gollin P.A., Kalaria R.N., Eikelenboom P., Rozemuller A., Perry G. Alpha 1-antitrypsin and alpha 1-antichymotrypsin are in the lesions of Alzheimer’s disease. Neuroreport. 1992;3:201–203. doi: 10.1097/00001756-199202000-00020.</cite> [<a href="https://doi.org/10.1097/00001756-199202000-00020" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1623174/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Neuroreport&amp;title=Alpha%201-antitrypsin%20and%20alpha%201-antichymotrypsin%20are%20in%20the%20lesions%20of%20Alzheimer%E2%80%99s%20disease&amp;author=P.A.%20Gollin&amp;author=R.N.%20Kalaria&amp;author=P.%20Eikelenboom&amp;author=A.%20Rozemuller&amp;author=G.%20Perry&amp;volume=3&amp;publication_year=1992&amp;pages=201-203&amp;pmid=1623174&amp;doi=10.1097/00001756-199202000-00020&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B28-ijms-22-09488">
<span class="label">28.</span><cite>Bohrmann B., Tjernberg L., Kuner P., Poli S., Levet-Trafit B., Naslund J., Richards G., Huber W., Dobeli H., Nordstedt C. Endogenous proteins controlling amyloid beta-peptide polymerization. Possible implications for beta-amyloid formation in the central nervous system and in peripheral tissues. J. Biol. Chem. 1999;274:15990–15995. doi: 10.1074/jbc.274.23.15990.</cite> [<a href="https://doi.org/10.1074/jbc.274.23.15990" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/10347147/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Endogenous%20proteins%20controlling%20amyloid%20beta-peptide%20polymerization.%20Possible%20implications%20for%20beta-amyloid%20formation%20in%20the%20central%20nervous%20system%20and%20in%20peripheral%20tissues&amp;author=B.%20Bohrmann&amp;author=L.%20Tjernberg&amp;author=P.%20Kuner&amp;author=S.%20Poli&amp;author=B.%20Levet-Trafit&amp;volume=274&amp;publication_year=1999&amp;pages=15990-15995&amp;pmid=10347147&amp;doi=10.1074/jbc.274.23.15990&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B29-ijms-22-09488">
<span class="label">29.</span><cite>Torricelli C., Capurro E., Santucci A., Paffetti A., D’Ambrosio C., Scaloni A., Maioli E., Pacini A. Multiple plasma proteins control atrial natriuretic peptide (ANP) aggregation. J. Mol. Endocrinol. 2004;33:335–341. doi: 10.1677/jme.1.01530.</cite> [<a href="https://doi.org/10.1677/jme.1.01530" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/15525593/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Mol.%20Endocrinol.&amp;title=Multiple%20plasma%20proteins%20control%20atrial%20natriuretic%20peptide%20(ANP)%20aggregation&amp;author=C.%20Torricelli&amp;author=E.%20Capurro&amp;author=A.%20Santucci&amp;author=A.%20Paffetti&amp;author=C.%20D%E2%80%99Ambrosio&amp;volume=33&amp;publication_year=2004&amp;pages=335-341&amp;pmid=15525593&amp;doi=10.1677/jme.1.01530&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B30-ijms-22-09488">
<span class="label">30.</span><cite>Heit C., Jackson B.C., McAndrews M., Wright M.W., Thompson D.C., Silverman G.A., Nebert D.W., Vasiliou V. Update of the human and mouse SERPIN gene superfamily. Hum. Genom. 2013;7:22. doi: 10.1186/1479-7364-7-22.</cite> [<a href="https://doi.org/10.1186/1479-7364-7-22" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3880077/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24172014/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Hum.%20Genom.&amp;title=Update%20of%20the%20human%20and%20mouse%20SERPIN%20gene%20superfamily&amp;author=C.%20Heit&amp;author=B.C.%20Jackson&amp;author=M.%20McAndrews&amp;author=M.W.%20Wright&amp;author=D.C.%20Thompson&amp;volume=7&amp;publication_year=2013&amp;pages=22&amp;pmid=24172014&amp;doi=10.1186/1479-7364-7-22&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B31-ijms-22-09488">
<span class="label">31.</span><cite>da Costa G., Ribeiro-Silva C., Ribeiro R., Gilberto S., Gomes R.A., Ferreira A., Mateus E., Barroso E., Coelho A.V., Freire A.P., et al.  Transthyretin Amyloidosis: Chaperone Concentration Changes and Increased Proteolysis in the Pathway to Disease. PLoS ONE. 2015;10:e0125392.  doi: 10.1371/journal.pone.0125392.</cite> [<a href="https://doi.org/10.1371/journal.pone.0125392" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4492746/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/26147092/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Transthyretin%20Amyloidosis:%20Chaperone%20Concentration%20Changes%20and%20Increased%20Proteolysis%20in%20the%20Pathway%20to%20Disease&amp;author=G.%20da%20Costa&amp;author=C.%20Ribeiro-Silva&amp;author=R.%20Ribeiro&amp;author=S.%20Gilberto&amp;author=R.A.%20Gomes&amp;volume=10&amp;publication_year=2015&amp;pages=e0125392&amp;pmid=26147092&amp;doi=10.1371/journal.pone.0125392&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B32-ijms-22-09488">
<span class="label">32.</span><cite>Chan G.G., Koch C.M., Connors L.H. Serum Proteomic Variability Associated with Clinical Phenotype in Familial Transthyretin Amyloidosis (ATTRm) J. Proteome Res. 2017;16:4104–4112. doi: 10.1021/acs.jproteome.7b00479.</cite> [<a href="https://doi.org/10.1021/acs.jproteome.7b00479" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28922609/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Proteome%20Res.&amp;title=Serum%20Proteomic%20Variability%20Associated%20with%20Clinical%20Phenotype%20in%20Familial%20Transthyretin%20Amyloidosis%20(ATTRm)&amp;author=G.G.%20Chan&amp;author=C.M.%20Koch&amp;author=L.H.%20Connors&amp;volume=16&amp;publication_year=2017&amp;pages=4104-4112&amp;pmid=28922609&amp;doi=10.1021/acs.jproteome.7b00479&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B33-ijms-22-09488">
<span class="label">33.</span><cite>Niemietz C., Fleischhauer L., Sandfort V., Guttmann S., Zibert A., Schmidt H.H. Hepatocyte-like cells reveal novel role of SERPINA1 in transthyretin amyloidosis. J. Cell Sci. 2018;131:jcs219824. doi: 10.1242/jcs.219824.</cite> [<a href="https://doi.org/10.1242/jcs.219824" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30333144/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cell%20Sci.&amp;title=Hepatocyte-like%20cells%20reveal%20novel%20role%20of%20SERPINA1%20in%20transthyretin%20amyloidosis&amp;author=C.%20Niemietz&amp;author=L.%20Fleischhauer&amp;author=V.%20Sandfort&amp;author=S.%20Guttmann&amp;author=A.%20Zibert&amp;volume=131&amp;publication_year=2018&amp;pages=jcs219824&amp;pmid=30333144&amp;doi=10.1242/jcs.219824&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B34-ijms-22-09488">
<span class="label">34.</span><cite>Niemietz C., Bezerra F., Almeida M.R., Guo S., Monia B.P., Saraiva M.J., Schutz P., Schmidt H.H., Zibert A. SERPINA1 modulates expression of amyloidogenic transthyretin. Exp. Cell Res. 2020;395:112217. doi: 10.1016/j.yexcr.2020.112217.</cite> [<a href="https://doi.org/10.1016/j.yexcr.2020.112217" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/32768500/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Exp.%20Cell%20Res.&amp;title=SERPINA1%20modulates%20expression%20of%20amyloidogenic%20transthyretin&amp;author=C.%20Niemietz&amp;author=F.%20Bezerra&amp;author=M.R.%20Almeida&amp;author=S.%20Guo&amp;author=B.P.%20Monia&amp;volume=395&amp;publication_year=2020&amp;pages=112217&amp;pmid=32768500&amp;doi=10.1016/j.yexcr.2020.112217&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B35-ijms-22-09488">
<span class="label">35.</span><cite>Teixeira A.C., Saraiva M.J. Presence of N-glycosylated transthyretin in plasma of V30M carriers in familial amyloidotic polyneuropathy: An escape from ERAD. J. Cell. Mol. Med. 2013;17:429–435. doi: 10.1111/jcmm.12024.</cite> [<a href="https://doi.org/10.1111/jcmm.12024" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC3823024/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/23387326/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Cell.%20Mol.%20Med.&amp;title=Presence%20of%20N-glycosylated%20transthyretin%20in%20plasma%20of%20V30M%20carriers%20in%20familial%20amyloidotic%20polyneuropathy:%20An%20escape%20from%20ERAD&amp;author=A.C.%20Teixeira&amp;author=M.J.%20Saraiva&amp;volume=17&amp;publication_year=2013&amp;pages=429-435&amp;pmid=23387326&amp;doi=10.1111/jcmm.12024&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B36-ijms-22-09488">
<span class="label">36.</span><cite>Suhr O.B., Lundgren E., Westermark P. One mutation, two distinct disease variants: Unravelling the impact of transthyretin amyloid fibril composition. J. Intern. Med. 2017;281:337–347. doi: 10.1111/joim.12585.</cite> [<a href="https://doi.org/10.1111/joim.12585" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28093848/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Intern.%20Med.&amp;title=One%20mutation,%20two%20distinct%20disease%20variants:%20Unravelling%20the%20impact%20of%20transthyretin%20amyloid%20fibril%20composition&amp;author=O.B.%20Suhr&amp;author=E.%20Lundgren&amp;author=P.%20Westermark&amp;volume=281&amp;publication_year=2017&amp;pages=337-347&amp;pmid=28093848&amp;doi=10.1111/joim.12585&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B37-ijms-22-09488">
<span class="label">37.</span><cite>Schormann N., Murrell J.R., Benson M.D. Tertiary structures of amyloidogenic and non-amyloidogenic transthyretin variants: New model for amyloid fibril formation. Amyloid Int. J. Exp. Clin. Investig. Off. J. Int. Soc. Amyloidosis. 1998;5:175–187. doi: 10.3109/13506129809003843.</cite> [<a href="https://doi.org/10.3109/13506129809003843" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/9818054/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid%20Int.%20J.%20Exp.%20Clin.%20Investig.%20Off.%20J.%20Int.%20Soc.%20Amyloidosis&amp;title=Tertiary%20structures%20of%20amyloidogenic%20and%20non-amyloidogenic%20transthyretin%20variants:%20New%20model%20for%20amyloid%20fibril%20formation&amp;author=N.%20Schormann&amp;author=J.R.%20Murrell&amp;author=M.D.%20Benson&amp;volume=5&amp;publication_year=1998&amp;pages=175-187&amp;pmid=9818054&amp;doi=10.3109/13506129809003843&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B38-ijms-22-09488">
<span class="label">38.</span><cite>Saelices L., Sievers S.A., Sawaya M.R., Eisenberg D.S. Crystal structures of amyloidogenic segments of human transthyretin. Protein Sci. Publ. Protein Soc. 2018;27:1295–1303. doi: 10.1002/pro.3420.</cite> [<a href="https://doi.org/10.1002/pro.3420" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6032358/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/29626847/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Protein%20Sci.%20Publ.%20Protein%20Soc.&amp;title=Crystal%20structures%20of%20amyloidogenic%20segments%20of%20human%20transthyretin&amp;author=L.%20Saelices&amp;author=S.A.%20Sievers&amp;author=M.R.%20Sawaya&amp;author=D.S.%20Eisenberg&amp;volume=27&amp;publication_year=2018&amp;pages=1295-1303&amp;pmid=29626847&amp;doi=10.1002/pro.3420&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B39-ijms-22-09488">
<span class="label">39.</span><cite>Dasari A.K.R., Hughes R.M., Wi S., Hung I., Gan Z., Kelly J.W., Lim K.H. Transthyretin Aggregation Pathway toward the Formation of Distinct Cytotoxic Oligomers. Sci. Rep. 2019;9:33. doi: 10.1038/s41598-018-37230-1.</cite> [<a href="https://doi.org/10.1038/s41598-018-37230-1" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6328637/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30631096/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Sci.%20Rep.&amp;title=Transthyretin%20Aggregation%20Pathway%20toward%20the%20Formation%20of%20Distinct%20Cytotoxic%20Oligomers&amp;author=A.K.R.%20Dasari&amp;author=R.M.%20Hughes&amp;author=S.%20Wi&amp;author=I.%20Hung&amp;author=Z.%20Gan&amp;volume=9&amp;publication_year=2019&amp;pages=33&amp;pmid=30631096&amp;doi=10.1038/s41598-018-37230-1&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B40-ijms-22-09488">
<span class="label">40.</span><cite>Stoppini M., Bellotti V. Systemic amyloidosis: Lessons from beta2-microglobulin. J. Biol. Chem. 2015;290:9951–9958. doi: 10.1074/jbc.R115.639799.</cite> [<a href="https://doi.org/10.1074/jbc.R115.639799" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4400370/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25750126/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Systemic%20amyloidosis:%20Lessons%20from%20beta2-microglobulin&amp;author=M.%20Stoppini&amp;author=V.%20Bellotti&amp;volume=290&amp;publication_year=2015&amp;pages=9951-9958&amp;pmid=25750126&amp;doi=10.1074/jbc.R115.639799&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B41-ijms-22-09488">
<span class="label">41.</span><cite>Sandgren O., Westermark P., Stenkula S. Relation of vitreous amyloidosis to prealbumin. Ophthalmic Res. 1986;18:98–103. doi: 10.1159/000265422.</cite> [<a href="https://doi.org/10.1159/000265422" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/3090496/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Ophthalmic%20Res.&amp;title=Relation%20of%20vitreous%20amyloidosis%20to%20prealbumin&amp;author=O.%20Sandgren&amp;author=P.%20Westermark&amp;author=S.%20Stenkula&amp;volume=18&amp;publication_year=1986&amp;pages=98-103&amp;pmid=3090496&amp;doi=10.1159/000265422&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B42-ijms-22-09488">
<span class="label">42.</span><cite>Liepnieks J.J., Wilson D.L., Benson M.D. Biochemical characterization of vitreous and cardiac amyloid in Ile84Ser transthyretin amyloidosis. Amyloid Int. J. Exp. Clin. Investig. Off. J. Int. Soc. Amyloidosis. 2006;13:170–177. doi: 10.1080/13506120600877003.</cite> [<a href="https://doi.org/10.1080/13506120600877003" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/17062384/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Amyloid%20Int.%20J.%20Exp.%20Clin.%20Investig.%20Off.%20J.%20Int.%20Soc.%20Amyloidosis&amp;title=Biochemical%20characterization%20of%20vitreous%20and%20cardiac%20amyloid%20in%20Ile84Ser%20transthyretin%20amyloidosis&amp;author=J.J.%20Liepnieks&amp;author=D.L.%20Wilson&amp;author=M.D.%20Benson&amp;volume=13&amp;publication_year=2006&amp;pages=170-177&amp;pmid=17062384&amp;doi=10.1080/13506120600877003&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B43-ijms-22-09488">
<span class="label">43.</span><cite>Oshima T., Kawahara S., Ueda M., Kawakami Y., Tanaka R., Okazaki T., Misumi Y., Obayashi K., Yamashita T., Ohya Y., et al.  Changes in pathological and biochemical findings of systemic tissue sites in familial amyloid polyneuropathy more than 10 years after liver transplantation. J. Neurol. Neurosurg. Psychiatry. 2014;85:740–746. doi: 10.1136/jnnp-2013-305973.</cite> [<a href="https://doi.org/10.1136/jnnp-2013-305973" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/24023270/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neurol.%20Neurosurg.%20Psychiatry&amp;title=Changes%20in%20pathological%20and%20biochemical%20findings%20of%20systemic%20tissue%20sites%20in%20familial%20amyloid%20polyneuropathy%20more%20than%2010%20years%20after%20liver%20transplantation&amp;author=T.%20Oshima&amp;author=S.%20Kawahara&amp;author=M.%20Ueda&amp;author=Y.%20Kawakami&amp;author=R.%20Tanaka&amp;volume=85&amp;publication_year=2014&amp;pages=740-746&amp;pmid=24023270&amp;doi=10.1136/jnnp-2013-305973&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B44-ijms-22-09488">
<span class="label">44.</span><cite>Suhr O.B., Wixner J., Anan I., Lundgren H.E., Wijayatunga P., Westermark P., Ihse E. Amyloid fibril composition within hereditary Val30Met (p. Val50Met) transthyretin amyloidosis families. PLoS ONE. 2019;14:e0211983.  doi: 10.1371/journal.pone.0211983.</cite> [<a href="https://doi.org/10.1371/journal.pone.0211983" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6392248/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/30811423/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=PLoS%20ONE&amp;title=Amyloid%20fibril%20composition%20within%20hereditary%20Val30Met%20(p.%20Val50Met)%20transthyretin%20amyloidosis%20families&amp;author=O.B.%20Suhr&amp;author=J.%20Wixner&amp;author=I.%20Anan&amp;author=H.E.%20Lundgren&amp;author=P.%20Wijayatunga&amp;volume=14&amp;publication_year=2019&amp;pages=e0211983&amp;pmid=30811423&amp;doi=10.1371/journal.pone.0211983&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B45-ijms-22-09488">
<span class="label">45.</span><cite>Constantinescu P., Brown R.A., Wyatt A.R., Ranson M., Wilson M.R. Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones. J. Biol. Chem. 2017;292:14425–14437. doi: 10.1074/jbc.M117.786657.</cite> [<a href="https://doi.org/10.1074/jbc.M117.786657" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5582837/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28710283/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=Amorphous%20protein%20aggregates%20stimulate%20plasminogen%20activation,%20leading%20to%20release%20of%20cytotoxic%20fragments%20that%20are%20clients%20for%20extracellular%20chaperones&amp;author=P.%20Constantinescu&amp;author=R.A.%20Brown&amp;author=A.R.%20Wyatt&amp;author=M.%20Ranson&amp;author=M.R.%20Wilson&amp;volume=292&amp;publication_year=2017&amp;pages=14425-14437&amp;pmid=28710283&amp;doi=10.1074/jbc.M117.786657&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B46-ijms-22-09488">
<span class="label">46.</span><cite>Ueda M., Okada M., Mizuguchi M., Kluve-Beckerman B., Kanenawa K., Isoguchi A., Misumi Y., Tasaki M., Ueda A., Kanai A., et al.  A cell-based high-throughput screening method to directly examine transthyretin amyloid fibril formation at neutral pH. J. Biol. Chem. 2019;294:11259–11275. doi: 10.1074/jbc.RA119.007851.</cite> [<a href="https://doi.org/10.1074/jbc.RA119.007851" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6643022/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31167790/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Biol.%20Chem.&amp;title=A%20cell-based%20high-throughput%20screening%20method%20to%20directly%20examine%20transthyretin%20amyloid%20fibril%20formation%20at%20neutral%20pH&amp;author=M.%20Ueda&amp;author=M.%20Okada&amp;author=M.%20Mizuguchi&amp;author=B.%20Kluve-Beckerman&amp;author=K.%20Kanenawa&amp;volume=294&amp;publication_year=2019&amp;pages=11259-11275&amp;pmid=31167790&amp;doi=10.1074/jbc.RA119.007851&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B47-ijms-22-09488">
<span class="label">47.</span><cite>Schmidt M., Wiese S., Adak V., Engler J., Agarwal S., Fritz G., Westermark P., Zacharias M., Fandrich M. Cryo-EM structure of a transthyretin-derived amyloid fibril from a patient with hereditary ATTR amyloidosis. Nat. Commun. 2019;10:5008. doi: 10.1038/s41467-019-13038-z.</cite> [<a href="https://doi.org/10.1038/s41467-019-13038-z" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC6825171/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/31676763/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Nat.%20Commun.&amp;title=Cryo-EM%20structure%20of%20a%20transthyretin-derived%20amyloid%20fibril%20from%20a%20patient%20with%20hereditary%20ATTR%20amyloidosis&amp;author=M.%20Schmidt&amp;author=S.%20Wiese&amp;author=V.%20Adak&amp;author=J.%20Engler&amp;author=S.%20Agarwal&amp;volume=10&amp;publication_year=2019&amp;pages=5008&amp;pmid=31676763&amp;doi=10.1038/s41467-019-13038-z&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B48-ijms-22-09488">
<span class="label">48.</span><cite>Guo S., Booten S.L., Watt A., Alvarado L., Freier S.M., Teckman J.H., McCaleb M.L., Monia B.P. Using antisense technology to develop a novel therapy for alpha-1 antitrypsin deficient (AATD) liver disease and to model AATD lung disease. Rare Dis. 2014;2:e28511. doi: 10.4161/rdis.28511.</cite> [<a href="https://doi.org/10.4161/rdis.28511" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC4091453/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/25054094/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Rare%20Dis.&amp;title=Using%20antisense%20technology%20to%20develop%20a%20novel%20therapy%20for%20alpha-1%20antitrypsin%20deficient%20(AATD)%20liver%20disease%20and%20to%20model%20AATD%20lung%20disease&amp;author=S.%20Guo&amp;author=S.L.%20Booten&amp;author=A.%20Watt&amp;author=L.%20Alvarado&amp;author=S.M.%20Freier&amp;volume=2&amp;publication_year=2014&amp;pages=e28511&amp;pmid=25054094&amp;doi=10.4161/rdis.28511&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B49-ijms-22-09488">
<span class="label">49.</span><cite>Furuya H., Saraiva M.J., Gawinowicz M.A., Alves I.L., Costa P.P., Sasaki H., Goto I., Sakaki Y. Production of recombinant human transthyretin with biological activities toward the understanding of the molecular basis of familial amyloidotic polyneuropathy (FAP) Biochemistry. 1991;30:2415–2421. doi: 10.1021/bi00223a017.</cite> [<a href="https://doi.org/10.1021/bi00223a017" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/1848097/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=Biochemistry&amp;title=Production%20of%20recombinant%20human%20transthyretin%20with%20biological%20activities%20toward%20the%20understanding%20of%20the%20molecular%20basis%20of%20familial%20amyloidotic%20polyneuropathy%20(FAP)&amp;author=H.%20Furuya&amp;author=M.J.%20Saraiva&amp;author=M.A.%20Gawinowicz&amp;author=I.L.%20Alves&amp;author=P.P.%20Costa&amp;volume=30&amp;publication_year=1991&amp;pages=2415-2421&amp;pmid=1848097&amp;doi=10.1021/bi00223a017&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B50-ijms-22-09488">
<span class="label">50.</span><cite>Osorio H., Silva C., Ferreira M., Gullo I., Maximo V., Barros R., Mendonca F., Oliveira C., Carneiro F. Proteomics Analysis of Gastric Cancer Patients with Diabetes Mellitus. J. Clin. Med. 2021;10:407.  doi: 10.3390/jcm10030407.</cite> [<a href="https://doi.org/10.3390/jcm10030407" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC7866049/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/33494396/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Clin.%20Med.&amp;title=Proteomics%20Analysis%20of%20Gastric%20Cancer%20Patients%20with%20Diabetes%20Mellitus&amp;author=H.%20Osorio&amp;author=C.%20Silva&amp;author=M.%20Ferreira&amp;author=I.%20Gullo&amp;author=V.%20Maximo&amp;volume=10&amp;publication_year=2021&amp;pages=407&amp;pmid=33494396&amp;doi=10.3390/jcm10030407&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
<li id="B51-ijms-22-09488">
<span class="label">51.</span><cite>Goncalves N.P., Moreira J., Martins D., Vieira P., Obici L., Merlini G., Saraiva M., Saraiva M.J. Differential expression of Cathepsin E in transthyretin amyloidosis: From neuropathology to the immune system. J. Neuroinflammation. 2017;14:115. doi: 10.1186/s12974-017-0891-9.</cite> [<a href="https://doi.org/10.1186/s12974-017-0891-9" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">DOI</a>] [<a href="/articles/PMC5460450/" class="usa-link">PMC free article</a>] [<a href="https://pubmed.ncbi.nlm.nih.gov/28583160/" class="usa-link">PubMed</a>] [<a href="https://scholar.google.com/scholar_lookup?journal=J.%20Neuroinflammation&amp;title=Differential%20expression%20of%20Cathepsin%20E%20in%20transthyretin%20amyloidosis:%20From%20neuropathology%20to%20the%20immune%20system&amp;author=N.P.%20Goncalves&amp;author=J.%20Moreira&amp;author=D.%20Martins&amp;author=P.%20Vieira&amp;author=L.%20Obici&amp;volume=14&amp;publication_year=2017&amp;pages=115&amp;pmid=28583160&amp;doi=10.1186/s12974-017-0891-9&amp;" class="usa-link usa-link--external" data-ga-action="click_feat_suppl" target="_blank" rel="noopener noreferrer">Google Scholar</a>]</li>
</ul></section></section><section id="_ad93_" lang="en" class="associated-data"><h2 class="pmc_sec_title">Associated Data</h2>
<p class="font-secondary"><em>This section collects any data citations, data availability statements, or supplementary materials included in this article.</em></p>
<section id="_adsm93_" lang="en" class="supplementary-materials"><h3 class="pmc_sec_title">Supplementary Materials</h3>
<section class="sm xbox font-sm" id="db_ds_supplementary-material1_reqid_"><div class="media p"><div class="caption">
<a href="/articles/instance/8430710/bin/ijms-22-09488-s001.zip" data-ga-action="click_feat_suppl" class="usa-link">Click here for additional data file.</a><sup> (1.2MB, zip) </sup>
</div></div></section></section><section id="_adda93_" lang="en" class="data-availability-statement"><h3 class="pmc_sec_title">Data Availability Statement</h3>
<p>Data are contained within the article or <a href="#app1-ijms-22-09488" class="usa-link">Supplementary Materials</a>.</p></section></section></section><footer class="p courtesy-note font-secondary font-sm text-center"><hr class="headless">
<p>Articles from International Journal of Molecular Sciences are provided here courtesy of <strong>Multidisciplinary Digital Publishing Institute  (MDPI)</strong></p></footer></section></article>

                      

                    </main>
                </div>
            </div>
        </div>

        



<!-- Secondary navigation placeholder -->
<div class="pmc-sidenav desktop:grid-col-4 display-flex">
    <section class="pmc-sidenav__container" aria-label="Article resources and navigation">
        <button type="button" class="usa-button pmc-sidenav__container__close usa-button--unstyled">
            <img src="/static/img/usa-icons/close.svg" role="img" alt="Close" />
        </button>
    <div class="display-none desktop:display-block">
       <section class="margin-top-4 desktop:margin-top-0">
              <h2 class="margin-top-0">ACTIONS</h2>
           <ul class="usa-list usa-list--unstyled usa-list--actions">
               
               <li>
                     <a
                             href="https://doi.org/10.3390/ijms22179488"
                             class="usa-button usa-button--outline width-24 font-xs display-inline-flex flex-align-center flex-justify-start padding-left-1"
                             target="_blank"
                             rel="noreferrer noopener"
                             data-ga-category="actions"
                             data-ga-action="click"
                             data-ga-label="publisher_link_desktop"
                     >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#launch"></use>
                         </svg>
                         <span class="display-inline-flex flex-justify-center flex-1 padding-right-2">View on publisher site</span>
                     </a>
               </li>
               
               
               <li>
                    <a
                            href="pdf/ijms-22-09488.pdf"
                            class="usa-button usa-button--outline width-24 display-inline-flex flex-align-center flex-justify-start padding-left-1"
                            data-ga-category="actions"
                            data-ga-action="click"
                            data-ga-label="pdf_download_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#file_download"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1">PDF (2.6 MB)</span>
                    </a>
               </li>
               
                
               <li>
                   <button role="button" class="usa-button width-24 citation-dialog-trigger display-inline-flex flex-align-center flex-justify-start padding-left-1"
                        aria-label="Open dialog with citation text in different styles"
                        data-ga-category="actions"
                        data-ga-action="open"
                        data-ga-label="cite_desktop"
                        data-all-citations-url="/resources/citations/8430710/"
                        data-citation-style="nlm"
                        data-download-format-link="/resources/citations/8430710/export/"
                    >
                        <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#format_quote"></use>
                        </svg>
                       <span class="display-inline-flex flex-justify-center flex-1 button-label">Cite</span>
                    </button>
               </li>
                
               <li>

                        <button class="usa-button width-24 collections-dialog-trigger collections-button display-inline-flex flex-align-center flex-justify-start padding-left-1 collections-button-empty"
                              aria-label="Save article in MyNCBI collections."
                              data-ga-category="actions"
                              data-ga-action="click"
                              data-ga-label="collections_button_desktop"
                              data-collections-open-dialog-enabled="false"
                              data-collections-open-dialog-url="https://account.ncbi.nlm.nih.gov/?back_url=https%3A%2F%2Fpmc.ncbi.nlm.nih.gov%2Farticles%2FPMC8430710%2F%23open-collections-dialog"
                              data-in-collections="false">
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-full" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-full.svg#icon"></use>
                            </svg>
                            <svg class="usa-icon width-3 height-3 usa-icon--bookmark-empty" aria-hidden="true" focusable="false" role="img" hidden>
                                <use xlink:href="/static/img/action-bookmark-empty.svg#icon"></use>
                            </svg>
                            <span class="display-inline-flex flex-justify-center flex-1">Collections</span>
                       </button>
               </li>
               <li class="pmc-permalink">
                    <button
                            type="button"
                            class="usa-button width-24 display-inline-flex flex-align-center flex-justify padding-left-1 shadow-none"
                            aria-label="Show article permalink"
                            aria-expanded="false"
                            aria-haspopup="true"
                            data-ga-category="actions"
                            data-ga-action="open"
                            data-ga-label="permalink_desktop"
                    >
                         <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img" hidden>
                            <use xlink:href="/static/img/sprite.svg#share"></use>
                        </svg>
                        <span class="display-inline-flex flex-justify-center flex-1 button-label">Permalink</span>
                    </button>
                   

<div class="pmc-permalink__dropdown" hidden>
    <div class="pmc-permalink__dropdown__container">
          <h2 class="usa-modal__heading margin-top-0 margin-bottom-2 text-uppercase font-sans-xs">PERMALINK</h2>
          <div class="pmc-permalink__dropdown__content">
              <input type="text" class="usa-input" value="https://pmc.ncbi.nlm.nih.gov/articles/PMC8430710/" aria-label="Article permalink">
              <button class="usa-button display-inline-flex pmc-permalink__dropdown__copy__btn margin-right-0" title="Copy article permalink" data-ga-category="save_share" data-ga-action="link" data-ga-label="copy_link">
                  <svg class="usa-icon" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#content_copy"></use>
                  </svg>
                  <span class="margin-left-1">Copy</span>
              </button>
          </div>
    </div>
</div>
               </li>
           </ul>
       </section>
     </div>

        <section class="pmc-resources margin-top-6 desktop:margin-top-4" data-page-path="/articles/PMC8430710/">
            <h2 class="margin-top-0">RESOURCES</h2>
            
                <div class="usa-accordion usa-accordion--multiselectable" data-allow-multiple>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-similar-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_similar_articles"
                        data-ga-label="/articles/PMC8430710/"
                        data-action-open="open_similar_articles"
                        data-action-close="close_similar_articles"
                        >
                            Similar articles
                        </button>
                    </h3>
                    <div
                            id="resources-similar-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/similar-article-links/34502397/"
                            
                    >
                        
                    </div>
                    <h3 class="usa-accordion__heading">
                        <button
                        type="button"
                        class="usa-accordion__button"
                        aria-expanded="false"
                        aria-controls="resources-cited-by-other-articles"
                        data-ga-category="resources_accordion"
                        data-ga-action="open_cited_by"
                        data-ga-label="/articles/PMC8430710/"
                        data-action-open="open_cited_by"
                        data-action-close="close_cited_by"
                        >
                             Cited by other articles
                        </button>
                    </h3>
                    <div
                            id="resources-cited-by-other-articles"
                            class="usa-accordion__content usa-prose"
                            
                                data-source-url="/resources/cited-by-links/34502397/"
                            
                    >
                          
                    </div>
                    
                        <h3 class="usa-accordion__heading">
                            <button
                            type="button"
                            class="usa-accordion__button"
                            aria-expanded="false"
                            aria-controls="resources-links-to-ncbi-databases"
                            data-ga-category="resources_accordion"
                            data-ga-action="open_NCBI_links"
                            data-ga-label="/articles/PMC8430710/"
                            data-action-open="open_NCBI_links"
                            data-action-close="close_NCBI_link"
                            >
                                 Links to NCBI Databases
                            </button>
                        </h3>
                        <div
                                id="resources-links-to-ncbi-databases"
                                class="usa-accordion__content usa-prose"
                                data-source-url="/resources/db-links/8430710/"
                        >
                        </div>
                    
                    
                </div>
            
        </section>


        <section
        class="usa-in-page-nav usa-in-page-nav--wide margin-top-6 desktop:margin-top-4"
        data-title-text="On this page"
        data-title-heading-level="h2"
        data-scroll-offset="0"
        data-root-margin="-10% 0px -80% 0px"
        data-main-content-selector="main"
        data-threshold="1"
        hidden
        ></section>
    </section>
</div>


        

<div class="overlay" role="dialog" aria-label="Citation Dialog" hidden>
    <div class="dialog citation-dialog" aria-hidden="true">
        <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
            <h2 class="usa-modal__heading margin-0">Cite</h2>
             <button type="button" class="usa-button usa-button--unstyled close-overlay text-black width-auto"  tabindex="1">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#close"></use>
                </svg>
             </button>
        </div>

        

<div class="citation-text-block">
  <div class="citation-text margin-bottom-2"></div>
  <ul class="usa-list usa-list--unstyled display-inline-flex flex-justify width-full flex-align-center">
      <li>
        <button
          class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center copy-button dialog-focus"
          data-ga-category="save_share"
          data-ga-action="cite"
          data-ga-label="copy"
          tabindex="2">
            <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                <use xlink:href="/static/img/sprite.svg#content_copy"></use>
            </svg>
            <span>Copy</span>
        </button>
      </li>
      <li>
          <a
              href="#"
              role="button"
              class="usa-button usa-button--unstyled text-no-underline display-flex flex-align-center export-button"
              data-ga-category="save_share"
              data-ga-action="cite"
              data-ga-label="download"
              title="Download a file for external citation management software"
              tabindex="3">
                <svg class="usa-icon width-3 height-3" aria-hidden="true" focusable="false" role="img">
                    <use xlink:href="/static/img/sprite.svg#file_download"></use>
                </svg>
                <span class="display-none mobile-lg:display-inline">Download .nbib</span>
                <span class="display-inline mobile-lg:display-none">.nbib</span>
            </a>
      </li>
      <li>
          

<div class="display-inline-flex flex-align-center">
  <label class="usa-label margin-top-0">Format:</label>
  <select aria-label="Format" class="usa-select citation-style-selector padding-1 margin-top-0 border-0 padding-right-4" tabindex="4" >
    
      <option data-style-url-name="ama"
              value="AMA"
              >
        AMA
      </option>
    
      <option data-style-url-name="apa"
              value="APA"
              >
        APA
      </option>
    
      <option data-style-url-name="mla"
              value="MLA"
              >
        MLA
      </option>
    
      <option data-style-url-name="nlm"
              value="NLM"
              selected="selected">
        NLM
      </option>
    
  </select>
</div>
      </li>
  </ul>
</div>
    </div>
</div>

        <div class="overlay" role="dialog" hidden>
  <div id="collections-action-dialog" class="dialog collections-dialog" aria-hidden="true">
   <div class="display-inline-flex flex-align-center flex-justify width-full margin-bottom-2">
        <h2 class="usa-modal__heading margin-0">Add to Collections</h2>
    </div>
    <div class="collections-action-panel action-panel">
      


<form id="collections-action-dialog-form"
      class="usa-form maxw-full collections-action-panel-form action-panel-content action-form action-panel-smaller-selectors"
      data-existing-collections-url="/list-existing-collections/"
      data-add-to-existing-collection-url="/add-to-existing-collection/"
      data-create-and-add-to-new-collection-url="/create-and-add-to-new-collection/"
      data-myncbi-max-collection-name-length="100"
      data-collections-root-url="https://www.ncbi.nlm.nih.gov/myncbi/collections/">

    <input type="hidden" name="csrfmiddlewaretoken" value="BUFqk68bLvepicsEFGAESXuy7AR4XO0iCDs7NRwnIRtVCFLZTUFkGBW8So7EAoHW">

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-new"
            class="usa-radio__input usa-radio__input--tile collections-new  margin-top-0"
            name="collections"
            value="new"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_new" />
            <label class="usa-radio__label" for="collections-action-dialog-new">Create a new collection</label>
        </div>
        <div class="usa-radio">
            <input type="radio"
            id="collections-action-dialog-existing"
            class="usa-radio__input usa-radio__input--tile collections-existing"
            name="collections"
            value="existing"
            checked="true"
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="collections_radio_existing" />
            <label class="usa-radio__label" for="collections-action-dialog-existing">Add to an existing collection</label>
        </div>
    </fieldset>

    <fieldset class="usa-fieldset margin-bottom-2">
        <div class="action-panel-control-wrap new-collections-controls">
           <label for="collections-action-dialog-add-to-new" class="usa-label margin-top-0">
                Name your collection
               <abbr title="required" class="usa-hint usa-hint--required text-no-underline">*</abbr>
          </label>
          <input
            type="text"
            name="add-to-new-collection"
            id="collections-action-dialog-add-to-new"
            class="usa-input collections-action-add-to-new"
            pattern="[^&quot;&amp;=&lt;&gt;/]*" title="The following characters are not allowed in the Name field: &quot;&amp;=&lt;&gt;/"
            maxlength=""
            data-ga-category="collections_button"
            data-ga-action="create_collection"
            data-ga-label="non_favorties_collection"
            required
          />
        </div>
        <div class="action-panel-control-wrap existing-collections-controls">
             <label for="collections-action-dialog-add-to-existing" class="usa-label margin-top-0">
                Choose a collection
              </label>
              <select id="collections-action-dialog-add-to-existing"
                      class="usa-select collections-action-add-to-existing"
                      data-ga-category="collections_button"
                      data-ga-action="select_collection"
                      data-ga-label="($('.collections-action-add-to-existing').val() === 'Favorites') ? 'Favorites' : 'non_favorites_collection'">
              </select>
              <div class="collections-retry-load-on-error usa-input-error-message selection-validation-message">
                Unable to load your collection due to an error<br>
                <a href="#">Please try again</a>
              </div>
        </div>
    </fieldset>

    <div class="display-inline-flex">
        <button class="usa-button margin-top-0 action-panel-submit"
            type="submit"
            data-loading-label="Adding..."
            data-pinger-ignore
            data-ga-category="collections_button"
            data-ga-action="click"
            data-ga-label="add">
          Add
        </button>
        <button class="usa-button usa-button--outline margin-top-0 action-panel-cancel"
                aria-label="Close 'Add to Collections' panel"
                ref="linksrc=close_collections_panel"
                data-ga-category="collections_button"
                data-ga-action="click"
                data-ga-label="cancel">
          Cancel
        </button>
    </div>
</form>
    </div>
  </div>
</div>

        

      </div>
    </div>
  </div>



        
    
    

<footer class="ncbi-footer ncbi-dark-background " >
    
        <div class="ncbi-footer__icon-section">
            <div class="ncbi-footer__social-header">
                Follow NCBI
            </div>

            <div class="grid-container ncbi-footer__ncbi-social-icons-container">
                
                    <a href="https://twitter.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="40"
                             height="40"
                             viewBox="0 0 40 40"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on X (formerly known as Twitter)</span>
                    </a>
                

                
                    <a href="https://www.facebook.com/ncbi.nlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="16"
                             height="29"
                             focusable="false"
                             aria-hidden="true"
                             viewBox="0 0 16 29"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg">
                            <path d="M3.8809 21.4002C3.8809 19.0932 3.8809 16.7876 3.8809 14.478C3.8809 14.2117 3.80103 14.1452 3.54278 14.1492C2.53372 14.1638 1.52334 14.1492 0.514288 14.1598C0.302626 14.1598 0.248047 14.0972 0.248047 13.8936C0.256034 12.4585 0.256034 11.0239 0.248047 9.58978C0.248047 9.37013 0.302626 9.30224 0.528931 9.3049C1.53798 9.31688 2.54837 9.3049 3.55742 9.31555C3.80103 9.31555 3.8809 9.26097 3.87957 9.00272C3.87158 8.00565 3.85428 7.00592 3.90753 6.00884C3.97142 4.83339 4.31487 3.73115 5.04437 2.78467C5.93095 1.63318 7.15699 1.09005 8.56141 0.967577C10.5582 0.79319 12.555 0.982221 14.5518 0.927641C14.7102 0.927641 14.7462 0.99287 14.7449 1.13664C14.7449 2.581 14.7449 4.02668 14.7449 5.47104C14.7449 5.67604 14.6517 5.68669 14.4946 5.68669C13.4523 5.68669 12.4113 5.68669 11.3703 5.68669C10.3506 5.68669 9.92057 6.10868 9.90593 7.13904C9.89661 7.7647 9.91525 8.39303 9.89794 9.01869C9.88995 9.26364 9.96583 9.31822 10.2015 9.31688C11.7204 9.30623 13.2393 9.31688 14.7595 9.3049C15.0257 9.3049 15.0723 9.3728 15.0444 9.62439C14.89 10.9849 14.7515 12.3467 14.6144 13.7085C14.5691 14.1571 14.5785 14.1585 14.1458 14.1585C12.8386 14.1585 11.5313 14.1665 10.2254 14.1518C9.95119 14.1518 9.89794 14.2317 9.89794 14.4899C9.90593 19.0799 9.89794 23.6752 9.91125 28.2612C9.91125 28.5674 9.8407 28.646 9.53186 28.6433C7.77866 28.6273 6.02414 28.6366 4.27094 28.634C3.82499 28.634 3.87158 28.6992 3.87158 28.22C3.87602 25.9472 3.87913 23.6739 3.8809 21.4002Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on Facebook</span>
                    </a>
                

                
                    <a href="https://www.linkedin.com/company/ncbinlm"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="25"
                             height="23"
                             viewBox="0 0 26 24"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M14.6983 9.98423C15.6302 9.24808 16.5926 8.74754 17.6762 8.51991C19.673 8.09126 21.554 8.30824 23.1262 9.7526C24.2351 10.7723 24.7529 12.1115 25.0165 13.5612C25.1486 14.3363 25.2105 15.1218 25.2015 15.9081C25.2015 18.3043 25.2015 20.6898 25.2082 23.0806C25.2082 23.3468 25.1549 23.444 24.8621 23.4414C23.1297 23.4272 21.3992 23.4272 19.6704 23.4414C19.4041 23.4414 19.3429 23.3588 19.3442 23.1019C19.3535 20.5194 19.3442 17.9368 19.3442 15.3543C19.3442 14.0005 18.3258 12.9448 17.0266 12.9488C15.7273 12.9528 14.6983 14.0071 14.6983 15.361C14.6983 17.9328 14.6917 20.5047 14.6983 23.0753C14.6983 23.3708 14.6198 23.444 14.3296 23.4427C12.6185 23.4294 10.9079 23.4294 9.19779 23.4427C8.93155 23.4427 8.86099 23.3735 8.86232 23.1086C8.8783 19.7619 8.88628 16.4144 8.88628 13.066C8.88628 11.5688 8.87874 10.0708 8.86365 8.57182C8.86365 8.3575 8.90758 8.27896 9.14054 8.28029C10.9048 8.29094 12.6687 8.29094 14.4321 8.28029C14.6464 8.28029 14.6983 8.34818 14.6983 8.54653C14.6903 9.00047 14.6983 9.45441 14.6983 9.98423Z">
                            </path>
                            <path d="M6.55316 15.8443C6.55316 18.2564 6.55316 20.6699 6.55316 23.082C6.55316 23.3629 6.48127 23.4388 6.19906 23.4374C4.47737 23.4241 2.75568 23.4241 1.03399 23.4374C0.767751 23.4374 0.69986 23.3629 0.701191 23.1006C0.709178 18.2648 0.709178 13.4281 0.701191 8.59053C0.701191 8.34026 0.765089 8.27237 1.01669 8.2737C2.74991 8.28435 4.48048 8.28435 6.20838 8.2737C6.47462 8.2737 6.5465 8.33627 6.54517 8.6065C6.54783 11.0186 6.55316 13.4308 6.55316 15.8443Z">
                            </path>
                            <path d="M3.65878 0.243898C5.36804 0.243898 6.58743 1.45529 6.58743 3.1406C6.58743 4.75801 5.32145 5.95742 3.60819 5.96807C3.22177 5.97614 2.83768 5.90639 2.47877 5.76299C2.11985 5.61959 1.79344 5.40546 1.51897 5.13334C1.24449 4.86123 1.02755 4.53668 0.881058 4.17902C0.734563 3.82136 0.661505 3.43788 0.666231 3.05141C0.67555 1.42601 1.9362 0.242566 3.65878 0.243898Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on LinkedIn</span>
                    </a>
                

                
                    <a href="https://github.com/ncbi"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="28"
                             height="27"
                             viewBox="0 0 28 28"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M16.7228 20.6334C17.5057 20.5527 18.2786 20.3944 19.0301 20.1608C21.3108 19.4193 22.5822 17.8259 22.963 15.4909C23.1228 14.5112 23.1814 13.5287 22.9883 12.5437C22.8106 11.6423 22.4013 10.8028 21.8007 10.1076C21.7526 10.0605 21.7197 10 21.7064 9.934C21.6931 9.86799 21.7 9.79952 21.7262 9.73748C22.0856 8.6206 21.9711 7.51969 21.601 6.42677C21.582 6.3497 21.5345 6.2827 21.468 6.23923C21.4016 6.19577 21.3211 6.17906 21.2429 6.19248C20.7329 6.21649 20.2313 6.33051 19.7611 6.52928C19.1103 6.7908 18.4899 7.12198 17.9104 7.51703C17.84 7.56996 17.7581 7.60551 17.6713 7.62078C17.5846 7.63605 17.4954 7.6306 17.4112 7.60489C15.2596 7.05882 13.0054 7.06203 10.8554 7.61421C10.7806 7.63586 10.7018 7.63967 10.6253 7.62534C10.5487 7.611 10.4766 7.57892 10.4148 7.53167C9.64788 7.03247 8.85171 6.58918 7.96368 6.33359C7.65781 6.24338 7.34123 6.19458 7.02239 6.18849C6.94879 6.17986 6.87462 6.19893 6.81432 6.242C6.75402 6.28507 6.71191 6.34904 6.69621 6.42145C6.32342 7.51437 6.2209 8.61527 6.56307 9.73348C6.59635 9.84264 6.64694 9.93316 6.54177 10.0516C5.47666 11.2604 5.09988 12.6834 5.19574 14.2676C5.2663 15.4244 5.46201 16.5466 6.01454 17.5769C6.84399 19.1171 8.21664 19.9119 9.85158 20.3352C10.3938 20.4706 10.9444 20.5698 11.4998 20.632C11.5384 20.7492 11.4506 20.7798 11.408 20.8291C11.1734 21.1179 10.9894 21.4441 10.8634 21.7942C10.7622 22.0458 10.8315 22.4039 10.6065 22.5516C10.263 22.7766 9.83827 22.8485 9.42421 22.8871C8.17936 23.0056 7.26471 22.4877 6.6283 21.4348C6.25552 20.8184 5.76956 20.3325 5.08523 20.0663C4.76981 19.9325 4.42139 19.8967 4.08537 19.9638C3.7898 20.029 3.73788 20.1901 3.93891 20.4111C4.03639 20.5234 4.14989 20.6207 4.27575 20.6999C4.9796 21.1318 5.51717 21.7884 5.80152 22.5636C6.37002 23.9973 7.48039 24.5697 8.93825 24.6323C9.43741 24.6575 9.93768 24.615 10.4254 24.5058C10.5892 24.4672 10.6531 24.4872 10.6517 24.6762C10.6451 25.4936 10.6637 26.3123 10.6517 27.131C10.6517 27.6635 10.1684 27.9297 9.58663 27.7393C8.17396 27.2671 6.84977 26.5631 5.66838 25.656C2.59555 23.2891 0.720966 20.1861 0.217704 16.3376C-0.357453 11.9127 0.911353 8.00824 3.98551 4.73881C6.11909 2.42656 8.99932 0.939975 12.1203 0.540191C16.5351 -0.0601815 20.4347 1.14323 23.7232 4.16373C26.2449 6.47869 27.724 9.37672 28.1048 12.7726C28.5828 17.0325 27.3686 20.7945 24.4768 23.9827C22.9762 25.6323 21.0956 26.8908 18.9982 27.6488C18.8783 27.6927 18.7585 27.738 18.636 27.7726C18.0356 27.9404 17.6189 27.6395 17.6189 27.0098C17.6189 25.7452 17.6308 24.4806 17.6295 23.2159C17.6329 22.9506 17.6128 22.6856 17.5696 22.4238C17.4325 21.6664 17.3419 21.484 16.7228 20.6334Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI on GitHub</span>
                    </a>
                

                
                    <a href="https://ncbiinsights.ncbi.nlm.nih.gov/"
                       class="ncbi-footer__social-icon ncbi-footer__social-icon--gray"
                       target="_blank"
                       rel="noreferrer noopener">
                        <svg width="26"
                             height="26"
                             viewBox="0 0 27 27"
                             fill="none"
                             xmlns="http://www.w3.org/2000/svg"
                             focusable="false"
                             aria-hidden="true">
                            <path d="M23.7778 26.4574C23.1354 26.3913 22.0856 26.8024 21.636 26.3087C21.212 25.8444 21.4359 24.8111 21.324 24.0347C19.9933 14.8323 14.8727 8.80132 6.09057 5.85008C4.37689 5.28406 2.58381 4.99533 0.779072 4.99481C0.202773 4.99481 -0.0229751 4.83146 0.00455514 4.21479C0.0660406 3.08627 0.0660406 1.95525 0.00455514 0.826734C-0.0413285 0.0815827 0.259669 -0.0193618 0.896534 0.00266238C6.96236 0.222904 12.3693 2.24179 16.9889 6.16209C22.9794 11.2478 26.1271 17.7688 26.4372 25.648C26.4629 26.294 26.3179 26.5271 25.6609 26.4684C25.0827 26.417 24.4991 26.4574 23.7778 26.4574Z">
                            </path>
                            <path d="M14.8265 26.441C14.0924 26.441 13.2371 26.6795 12.6626 26.3786C12.0092 26.0372 12.3781 25.0644 12.246 24.378C11.1154 18.5324 6.6849 14.5497 0.74755 14.1001C0.217135 14.0615 -0.0104482 13.9422 0.0134113 13.3659C0.0519536 12.1454 0.0482829 10.9213 0.0134113 9.69524C-0.00127145 9.14464 0.196946 9.03268 0.703502 9.04736C9.21217 9.27128 16.5994 16.2511 17.2804 24.7231C17.418 26.4446 17.418 26.4446 15.6579 26.4446H14.832L14.8265 26.441Z">
                            </path>
                            <path d="M3.58928 26.4555C2.64447 26.4618 1.73584 26.0925 1.06329 25.4289C0.39073 24.7653 0.00933763 23.8617 0.0030097 22.9169C-0.00331824 21.9721 0.365937 21.0635 1.02954 20.3909C1.69315 19.7184 2.59675 19.337 3.54156 19.3306C4.48637 19.3243 5.39499 19.6936 6.06755 20.3572C6.7401 21.0208 7.1215 21.9244 7.12782 22.8692C7.13415 23.814 6.7649 24.7226 6.10129 25.3952C5.43768 26.0677 4.53409 26.4491 3.58928 26.4555Z">
                            </path>
                        </svg>
                        <span class="usa-sr-only">NCBI RSS feed</span>
                    </a>
                
            </div>
        </div>
    

    <div data-testid="gridContainer"
         class="grid-container ncbi-footer__container">
        <div class="grid-row ncbi-footer__main-content-container"
             data-testid="grid">
            
                <div class="ncbi-footer__column">
                    
                        <p class="ncbi-footer__circled-icons-heading">
                            Connect with NLM
                        </p>
                    

                    <div class="ncbi-footer__circled-icons-list">
                        
                            <a href=https://twitter.com/nlm_nih class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="32"
                                     height="32"
                                     viewBox="0 0 40 40"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="m6.067 8 10.81 13.9L6 33.2h4.2l8.4-9.1 7.068 9.1H34L22.8 18.5 31.9 8h-3.5l-7.7 8.4L14.401 8H6.067Zm3.6 1.734h3.266l16.8 21.732H26.57L9.668 9.734Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on X (formerly known as Twitter)</span>
                            </a>
                        

                        
                            <a href=https://www.facebook.com/nationallibraryofmedicine class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="13"
                                     height="24"
                                     viewBox="0 0 13 24"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M4.11371 23.1369C4.11371 23.082 4.11371 23.0294 4.11371 22.9745V12.9411H0.817305C0.6709 12.9411 0.670898 12.9411 0.670898 12.8016C0.670898 11.564 0.670898 10.3287 0.670898 9.09341C0.670898 8.97903 0.705213 8.95158 0.815017 8.95158C1.8673 8.95158 2.91959 8.95158 3.97417 8.95158H4.12057V8.83263C4.12057 7.8055 4.12057 6.7738 4.12057 5.74897C4.1264 4.92595 4.31387 4.11437 4.66959 3.37217C5.12916 2.38246 5.94651 1.60353 6.95717 1.1921C7.64827 0.905008 8.3913 0.764035 9.13953 0.778051C10.0019 0.791777 10.8644 0.830666 11.7268 0.860404C11.8869 0.860404 12.047 0.894717 12.2072 0.90158C12.2964 0.90158 12.3261 0.940469 12.3261 1.02968C12.3261 1.5421 12.3261 2.05452 12.3261 2.56465C12.3261 3.16857 12.3261 3.7725 12.3261 4.37642C12.3261 4.48165 12.2964 4.51367 12.1912 4.51138C11.5369 4.51138 10.8804 4.51138 10.2261 4.51138C9.92772 4.51814 9.63058 4.5526 9.33855 4.61433C9.08125 4.6617 8.84537 4.78881 8.66431 4.97766C8.48326 5.16652 8.3662 5.40755 8.32972 5.66661C8.28476 5.89271 8.26027 6.1224 8.25652 6.35289C8.25652 7.19014 8.25652 8.02969 8.25652 8.86923C8.25652 8.89439 8.25652 8.91955 8.25652 8.95615H12.0219C12.1797 8.95615 12.182 8.95616 12.1614 9.10714C12.0768 9.76596 11.9876 10.4248 11.9029 11.0813C11.8312 11.6319 11.7626 12.1824 11.697 12.733C11.6719 12.9434 11.6787 12.9434 11.4683 12.9434H8.26338V22.899C8.26338 22.979 8.26338 23.0591 8.26338 23.1392L4.11371 23.1369Z">
                                    </path>
                                </svg>
                                <span class="usa-sr-only">NLM on Facebook</span>
                            </a>
                        

                        
                            <a href=https://www.youtube.com/user/NLMNIH class="ncbi-footer__social-icon ncbi-footer__social-icon--circled" target="_blank" rel="noreferrer noopener">
                                <svg width="21"
                                     height="15"
                                     viewBox="0 0 21 15"
                                     fill="none"
                                     xmlns="http://www.w3.org/2000/svg"
                                     focusable="false"
                                     aria-hidden="true">
                                    <path d="M19.2561 1.47914C18.9016 1.15888 18.5699 0.957569 17.2271 0.834039C15.5503 0.678484 13.2787 0.655608 11.563 0.65332H9.43556C7.71987 0.65332 5.4483 0.678484 3.77151 0.834039C2.43098 0.957569 2.097 1.15888 1.74242 1.47914C0.813665 2.32097 0.619221 4.62685 0.598633 6.89384C0.598633 7.31781 0.598633 7.74101 0.598633 8.16345C0.626084 10.4121 0.827391 12.686 1.74242 13.521C2.097 13.8412 2.4287 14.0425 3.77151 14.1661C5.4483 14.3216 7.71987 14.3445 9.43556 14.3468H11.563C13.2787 14.3468 15.5503 14.3216 17.2271 14.1661C18.5676 14.0425 18.9016 13.8412 19.2561 13.521C20.1712 12.6929 20.3725 10.451 20.3999 8.22064C20.3999 7.74025 20.3999 7.25986 20.3999 6.77946C20.3725 4.54907 20.1689 2.30724 19.2561 1.47914ZM8.55942 10.5311V4.65201L13.5601 7.50005L8.55942 10.5311Z"
                                          fill="white" />
                                </svg>
                                <span class="usa-sr-only">NLM on YouTube</span>
                            </a>
                        
                    </div>
                </div>
            

            
                <address class="ncbi-footer__address ncbi-footer__column">
                    
        <p>
            <a class="usa-link usa-link--external"
            href="https://www.google.com/maps/place/8600+Rockville+Pike,+Bethesda,+MD+20894/%4038.9959508,
            -77.101021,17z/data%3D!3m1!4b1!4m5!3m4!1s0x89b7c95e25765ddb%3A0x19156f88b27635b8!8m2!3d38.9959508!
            4d-77.0988323"
            rel="noopener noreferrer" target="_blank">National Library of Medicine
            <br/> 8600 Rockville Pike<br/> Bethesda, MD 20894</a>
        </p>
    
                </address>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/web_policies.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Web Policies
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nih.gov/institutes-nih/nih-office-director/office-communications-public-liaison/freedom-information-act-office" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            FOIA
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.hhs.gov/vulnerability-disclosure-policy/index.html" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS Vulnerability Disclosure
        

        
    </a>


                        </li>
                    
                </ul>
            

            
                <ul class="usa-list usa-list--unstyled ncbi-footer__vertical-list ncbi-footer__column">
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://support.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Help
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/accessibility.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Accessibility
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__vertical-list-item">
                            









    <a href="https://www.nlm.nih.gov/careers/careers.html" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            Careers
        

        
    </a>


                        </li>
                    
                </ul>
            
        </div>

        
            <div class="grid-row grid-col-12" data-testid="grid">
                <ul class="ncbi-footer__bottom-links-list">
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nlm.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NLM
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.nih.gov/" class="usa-link  usa-link--alt ncbi-footer__link"  >
        

        
            NIH
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.hhs.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            HHS
        

        
    </a>


                        </li>
                    
                        <li class="ncbi-footer__bottom-list-item">
                            









    <a href="https://www.usa.gov/" class="usa-link usa-link--external usa-link--alt ncbi-footer__link" rel="noreferrer noopener" target='_blank' >
        

        
            USA.gov
        

        
    </a>


                        </li>
                    
                </ul>
            </div>
        
    </div>
</footer>

    


        
        
    
  <script  type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/pinger/pinger.js"> </script>


    
        

<button class="back-to-top" data-ga-category="pagination" data-ga-action="back_to_top">
    <label>Back to Top</label>
    <svg class="usa-icon order-0" aria-hidden="true" focusable="false" role="img">
        <use xlink:href="/static/img/sprite.svg#arrow_upward"></use>
    </svg>
</button>
    


        
    
    
    
        
    <script type="application/javascript">
    window.ncbi = window.ncbi || {};
    window.ncbi.pmc = window.ncbi.pmc || {};
    window.ncbi.pmc.options = {
        logLevel: 'INFO',
        
        staticEndpoint: '/static/',
        
        citeCookieName: 'pmc-cf',
    };
</script>
    <script type="module" crossorigin="" src="/static/assets/base-133c6271.js"></script>
    
    <script type="text/javascript" src="https://cdn.ncbi.nlm.nih.gov/core/jquery/jquery-3.6.0.min.js">&#xA0;</script>
    <script type="text/javascript">
        jQuery.getScript("https://cdn.ncbi.nlm.nih.gov/core/alerts/alerts.js", function () {
            galert(['div.nav_and_browser', 'div.header', '#universal_header', '.usa-banner', 'body > *:nth-child(1)'])
        });
    </script>


    <script type="text/javascript">var exports = {};</script>
     <script src="/static/CACHE/js/output.13b077bc3ffd.js"></script>

    <script type="module" crossorigin="" src="/static/assets/article-44d04358.js"></script>
    
    

    </body>
</html>
